<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04CVKZ" lang="spa" raw_text_char_length="5656" raw_text_md5="248780a39ccbf1a266699bfb203abfab" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="135" id="segment-0" start_char="1">
<ORIGINAL_TEXT>Actualización del coronavirus (COVID-19): La FDA revoca la autorización de uso de emergencia para el anticuerpo monoclonal bamlanivimab</ORIGINAL_TEXT>
<TOKEN end_char="13" id="token-0-0" morph="none" pos="word" start_char="1">Actualización</TOKEN>
<TOKEN end_char="17" id="token-0-1" morph="none" pos="word" start_char="15">del</TOKEN>
<TOKEN end_char="29" id="token-0-2" morph="none" pos="word" start_char="19">coronavirus</TOKEN>
<TOKEN end_char="31" id="token-0-3" morph="none" pos="punct" start_char="31">(</TOKEN>
<TOKEN end_char="39" id="token-0-4" morph="none" pos="unknown" start_char="32">COVID-19</TOKEN>
<TOKEN end_char="41" id="token-0-5" morph="none" pos="punct" start_char="40">):</TOKEN>
<TOKEN end_char="44" id="token-0-6" morph="none" pos="word" start_char="43">La</TOKEN>
<TOKEN end_char="48" id="token-0-7" morph="none" pos="word" start_char="46">FDA</TOKEN>
<TOKEN end_char="55" id="token-0-8" morph="none" pos="word" start_char="50">revoca</TOKEN>
<TOKEN end_char="58" id="token-0-9" morph="none" pos="word" start_char="57">la</TOKEN>
<TOKEN end_char="71" id="token-0-10" morph="none" pos="word" start_char="60">autorización</TOKEN>
<TOKEN end_char="74" id="token-0-11" morph="none" pos="word" start_char="73">de</TOKEN>
<TOKEN end_char="78" id="token-0-12" morph="none" pos="word" start_char="76">uso</TOKEN>
<TOKEN end_char="81" id="token-0-13" morph="none" pos="word" start_char="80">de</TOKEN>
<TOKEN end_char="92" id="token-0-14" morph="none" pos="word" start_char="83">emergencia</TOKEN>
<TOKEN end_char="97" id="token-0-15" morph="none" pos="word" start_char="94">para</TOKEN>
<TOKEN end_char="100" id="token-0-16" morph="none" pos="word" start_char="99">el</TOKEN>
<TOKEN end_char="111" id="token-0-17" morph="none" pos="word" start_char="102">anticuerpo</TOKEN>
<TOKEN end_char="122" id="token-0-18" morph="none" pos="word" start_char="113">monoclonal</TOKEN>
<TOKEN end_char="135" id="token-0-19" morph="none" pos="word" start_char="124">bamlanivimab</TOKEN>
<TRANSLATED_TEXT>Coronavirus Update (COVID-19): FDA revokes emergency use authorization for the monoclonal antibody bamlanivimab</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="507" id="segment-1" start_char="139">
<ORIGINAL_TEXT>La Administración de Alimentos y Medicamentos (FDA, por sus siglas en inglés) de los EE.UU. revocó la autorización de uso de emergencia (EUA, por sus siglas en inglés) que permitía la terapia experimental de anticuerpos monoclonales bamlanivimab, cuando se administra solo, para el tratamiento del COVID-19 de leve a moderado en adultos y ciertos pacientes pediátricos.</ORIGINAL_TEXT>
<TOKEN end_char="140" id="token-1-0" morph="none" pos="word" start_char="139">La</TOKEN>
<TOKEN end_char="155" id="token-1-1" morph="none" pos="word" start_char="142">Administración</TOKEN>
<TOKEN end_char="158" id="token-1-2" morph="none" pos="word" start_char="157">de</TOKEN>
<TOKEN end_char="168" id="token-1-3" morph="none" pos="word" start_char="160">Alimentos</TOKEN>
<TOKEN end_char="170" id="token-1-4" morph="none" pos="word" start_char="170">y</TOKEN>
<TOKEN end_char="183" id="token-1-5" morph="none" pos="word" start_char="172">Medicamentos</TOKEN>
<TOKEN end_char="185" id="token-1-6" morph="none" pos="punct" start_char="185">(</TOKEN>
<TOKEN end_char="188" id="token-1-7" morph="none" pos="word" start_char="186">FDA</TOKEN>
<TOKEN end_char="189" id="token-1-8" morph="none" pos="punct" start_char="189">,</TOKEN>
<TOKEN end_char="193" id="token-1-9" morph="none" pos="word" start_char="191">por</TOKEN>
<TOKEN end_char="197" id="token-1-10" morph="none" pos="word" start_char="195">sus</TOKEN>
<TOKEN end_char="204" id="token-1-11" morph="none" pos="word" start_char="199">siglas</TOKEN>
<TOKEN end_char="207" id="token-1-12" morph="none" pos="word" start_char="206">en</TOKEN>
<TOKEN end_char="214" id="token-1-13" morph="none" pos="word" start_char="209">inglés</TOKEN>
<TOKEN end_char="215" id="token-1-14" morph="none" pos="punct" start_char="215">)</TOKEN>
<TOKEN end_char="218" id="token-1-15" morph="none" pos="word" start_char="217">de</TOKEN>
<TOKEN end_char="222" id="token-1-16" morph="none" pos="word" start_char="220">los</TOKEN>
<TOKEN end_char="228" id="token-1-17" morph="none" pos="unknown" start_char="224">EE.UU</TOKEN>
<TOKEN end_char="229" id="token-1-18" morph="none" pos="punct" start_char="229">.</TOKEN>
<TOKEN end_char="236" id="token-1-19" morph="none" pos="word" start_char="231">revocó</TOKEN>
<TOKEN end_char="239" id="token-1-20" morph="none" pos="word" start_char="238">la</TOKEN>
<TOKEN end_char="252" id="token-1-21" morph="none" pos="word" start_char="241">autorización</TOKEN>
<TOKEN end_char="255" id="token-1-22" morph="none" pos="word" start_char="254">de</TOKEN>
<TOKEN end_char="259" id="token-1-23" morph="none" pos="word" start_char="257">uso</TOKEN>
<TOKEN end_char="262" id="token-1-24" morph="none" pos="word" start_char="261">de</TOKEN>
<TOKEN end_char="273" id="token-1-25" morph="none" pos="word" start_char="264">emergencia</TOKEN>
<TOKEN end_char="275" id="token-1-26" morph="none" pos="punct" start_char="275">(</TOKEN>
<TOKEN end_char="278" id="token-1-27" morph="none" pos="word" start_char="276">EUA</TOKEN>
<TOKEN end_char="279" id="token-1-28" morph="none" pos="punct" start_char="279">,</TOKEN>
<TOKEN end_char="283" id="token-1-29" morph="none" pos="word" start_char="281">por</TOKEN>
<TOKEN end_char="287" id="token-1-30" morph="none" pos="word" start_char="285">sus</TOKEN>
<TOKEN end_char="294" id="token-1-31" morph="none" pos="word" start_char="289">siglas</TOKEN>
<TOKEN end_char="297" id="token-1-32" morph="none" pos="word" start_char="296">en</TOKEN>
<TOKEN end_char="304" id="token-1-33" morph="none" pos="word" start_char="299">inglés</TOKEN>
<TOKEN end_char="305" id="token-1-34" morph="none" pos="punct" start_char="305">)</TOKEN>
<TOKEN end_char="309" id="token-1-35" morph="none" pos="word" start_char="307">que</TOKEN>
<TOKEN end_char="318" id="token-1-36" morph="none" pos="word" start_char="311">permitía</TOKEN>
<TOKEN end_char="321" id="token-1-37" morph="none" pos="word" start_char="320">la</TOKEN>
<TOKEN end_char="329" id="token-1-38" morph="none" pos="word" start_char="323">terapia</TOKEN>
<TOKEN end_char="342" id="token-1-39" morph="none" pos="word" start_char="331">experimental</TOKEN>
<TOKEN end_char="345" id="token-1-40" morph="none" pos="word" start_char="344">de</TOKEN>
<TOKEN end_char="357" id="token-1-41" morph="none" pos="word" start_char="347">anticuerpos</TOKEN>
<TOKEN end_char="370" id="token-1-42" morph="none" pos="word" start_char="359">monoclonales</TOKEN>
<TOKEN end_char="383" id="token-1-43" morph="none" pos="word" start_char="372">bamlanivimab</TOKEN>
<TOKEN end_char="384" id="token-1-44" morph="none" pos="punct" start_char="384">,</TOKEN>
<TOKEN end_char="391" id="token-1-45" morph="none" pos="word" start_char="386">cuando</TOKEN>
<TOKEN end_char="394" id="token-1-46" morph="none" pos="word" start_char="393">se</TOKEN>
<TOKEN end_char="405" id="token-1-47" morph="none" pos="word" start_char="396">administra</TOKEN>
<TOKEN end_char="410" id="token-1-48" morph="none" pos="word" start_char="407">solo</TOKEN>
<TOKEN end_char="411" id="token-1-49" morph="none" pos="punct" start_char="411">,</TOKEN>
<TOKEN end_char="416" id="token-1-50" morph="none" pos="word" start_char="413">para</TOKEN>
<TOKEN end_char="419" id="token-1-51" morph="none" pos="word" start_char="418">el</TOKEN>
<TOKEN end_char="431" id="token-1-52" morph="none" pos="word" start_char="421">tratamiento</TOKEN>
<TOKEN end_char="435" id="token-1-53" morph="none" pos="word" start_char="433">del</TOKEN>
<TOKEN end_char="444" id="token-1-54" morph="none" pos="unknown" start_char="437">COVID-19</TOKEN>
<TOKEN end_char="447" id="token-1-55" morph="none" pos="word" start_char="446">de</TOKEN>
<TOKEN end_char="452" id="token-1-56" morph="none" pos="word" start_char="449">leve</TOKEN>
<TOKEN end_char="454" id="token-1-57" morph="none" pos="word" start_char="454">a</TOKEN>
<TOKEN end_char="463" id="token-1-58" morph="none" pos="word" start_char="456">moderado</TOKEN>
<TOKEN end_char="466" id="token-1-59" morph="none" pos="word" start_char="465">en</TOKEN>
<TOKEN end_char="474" id="token-1-60" morph="none" pos="word" start_char="468">adultos</TOKEN>
<TOKEN end_char="476" id="token-1-61" morph="none" pos="word" start_char="476">y</TOKEN>
<TOKEN end_char="484" id="token-1-62" morph="none" pos="word" start_char="478">ciertos</TOKEN>
<TOKEN end_char="494" id="token-1-63" morph="none" pos="word" start_char="486">pacientes</TOKEN>
<TOKEN end_char="506" id="token-1-64" morph="none" pos="word" start_char="496">pediátricos</TOKEN>
<TOKEN end_char="507" id="token-1-65" morph="none" pos="punct" start_char="507">.</TOKEN>
<TRANSLATED_TEXT>The U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (US) allowing experimental therapy of bamlanivimab monoclonal antibodies, when administered alone, for the treatment of COVID-19 from mild to moderate in adults and certain pediatric patients.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="943" id="segment-2" start_char="509">
<ORIGINAL_TEXT>Basándose en su análisis en curso de los datos científicos emergentes, específicamente el aumento sostenido de las variantes virales del SARS-CoV-2 que son resistentes al bamlanivimab solo, lo que resulta en un mayor riesgo de fracaso del tratamiento, la FDA ha determinado que los beneficios conocidos y potenciales del bamlanivimab, cuando se administra solo, ya no superan los riesgos conocidos y potenciales para su uso autorizado.</ORIGINAL_TEXT>
<TOKEN end_char="517" id="token-2-0" morph="none" pos="word" start_char="509">Basándose</TOKEN>
<TOKEN end_char="520" id="token-2-1" morph="none" pos="word" start_char="519">en</TOKEN>
<TOKEN end_char="523" id="token-2-2" morph="none" pos="word" start_char="522">su</TOKEN>
<TOKEN end_char="532" id="token-2-3" morph="none" pos="word" start_char="525">análisis</TOKEN>
<TOKEN end_char="535" id="token-2-4" morph="none" pos="word" start_char="534">en</TOKEN>
<TOKEN end_char="541" id="token-2-5" morph="none" pos="word" start_char="537">curso</TOKEN>
<TOKEN end_char="544" id="token-2-6" morph="none" pos="word" start_char="543">de</TOKEN>
<TOKEN end_char="548" id="token-2-7" morph="none" pos="word" start_char="546">los</TOKEN>
<TOKEN end_char="554" id="token-2-8" morph="none" pos="word" start_char="550">datos</TOKEN>
<TOKEN end_char="566" id="token-2-9" morph="none" pos="word" start_char="556">científicos</TOKEN>
<TOKEN end_char="577" id="token-2-10" morph="none" pos="word" start_char="568">emergentes</TOKEN>
<TOKEN end_char="578" id="token-2-11" morph="none" pos="punct" start_char="578">,</TOKEN>
<TOKEN end_char="594" id="token-2-12" morph="none" pos="word" start_char="580">específicamente</TOKEN>
<TOKEN end_char="597" id="token-2-13" morph="none" pos="word" start_char="596">el</TOKEN>
<TOKEN end_char="605" id="token-2-14" morph="none" pos="word" start_char="599">aumento</TOKEN>
<TOKEN end_char="615" id="token-2-15" morph="none" pos="word" start_char="607">sostenido</TOKEN>
<TOKEN end_char="618" id="token-2-16" morph="none" pos="word" start_char="617">de</TOKEN>
<TOKEN end_char="622" id="token-2-17" morph="none" pos="word" start_char="620">las</TOKEN>
<TOKEN end_char="632" id="token-2-18" morph="none" pos="word" start_char="624">variantes</TOKEN>
<TOKEN end_char="640" id="token-2-19" morph="none" pos="word" start_char="634">virales</TOKEN>
<TOKEN end_char="644" id="token-2-20" morph="none" pos="word" start_char="642">del</TOKEN>
<TOKEN end_char="655" id="token-2-21" morph="none" pos="unknown" start_char="646">SARS-CoV-2</TOKEN>
<TOKEN end_char="659" id="token-2-22" morph="none" pos="word" start_char="657">que</TOKEN>
<TOKEN end_char="663" id="token-2-23" morph="none" pos="word" start_char="661">son</TOKEN>
<TOKEN end_char="675" id="token-2-24" morph="none" pos="word" start_char="665">resistentes</TOKEN>
<TOKEN end_char="678" id="token-2-25" morph="none" pos="word" start_char="677">al</TOKEN>
<TOKEN end_char="691" id="token-2-26" morph="none" pos="word" start_char="680">bamlanivimab</TOKEN>
<TOKEN end_char="696" id="token-2-27" morph="none" pos="word" start_char="693">solo</TOKEN>
<TOKEN end_char="697" id="token-2-28" morph="none" pos="punct" start_char="697">,</TOKEN>
<TOKEN end_char="700" id="token-2-29" morph="none" pos="word" start_char="699">lo</TOKEN>
<TOKEN end_char="704" id="token-2-30" morph="none" pos="word" start_char="702">que</TOKEN>
<TOKEN end_char="712" id="token-2-31" morph="none" pos="word" start_char="706">resulta</TOKEN>
<TOKEN end_char="715" id="token-2-32" morph="none" pos="word" start_char="714">en</TOKEN>
<TOKEN end_char="718" id="token-2-33" morph="none" pos="word" start_char="717">un</TOKEN>
<TOKEN end_char="724" id="token-2-34" morph="none" pos="word" start_char="720">mayor</TOKEN>
<TOKEN end_char="731" id="token-2-35" morph="none" pos="word" start_char="726">riesgo</TOKEN>
<TOKEN end_char="734" id="token-2-36" morph="none" pos="word" start_char="733">de</TOKEN>
<TOKEN end_char="742" id="token-2-37" morph="none" pos="word" start_char="736">fracaso</TOKEN>
<TOKEN end_char="746" id="token-2-38" morph="none" pos="word" start_char="744">del</TOKEN>
<TOKEN end_char="758" id="token-2-39" morph="none" pos="word" start_char="748">tratamiento</TOKEN>
<TOKEN end_char="759" id="token-2-40" morph="none" pos="punct" start_char="759">,</TOKEN>
<TOKEN end_char="762" id="token-2-41" morph="none" pos="word" start_char="761">la</TOKEN>
<TOKEN end_char="766" id="token-2-42" morph="none" pos="word" start_char="764">FDA</TOKEN>
<TOKEN end_char="769" id="token-2-43" morph="none" pos="word" start_char="768">ha</TOKEN>
<TOKEN end_char="781" id="token-2-44" morph="none" pos="word" start_char="771">determinado</TOKEN>
<TOKEN end_char="785" id="token-2-45" morph="none" pos="word" start_char="783">que</TOKEN>
<TOKEN end_char="789" id="token-2-46" morph="none" pos="word" start_char="787">los</TOKEN>
<TOKEN end_char="800" id="token-2-47" morph="none" pos="word" start_char="791">beneficios</TOKEN>
<TOKEN end_char="810" id="token-2-48" morph="none" pos="word" start_char="802">conocidos</TOKEN>
<TOKEN end_char="812" id="token-2-49" morph="none" pos="word" start_char="812">y</TOKEN>
<TOKEN end_char="824" id="token-2-50" morph="none" pos="word" start_char="814">potenciales</TOKEN>
<TOKEN end_char="828" id="token-2-51" morph="none" pos="word" start_char="826">del</TOKEN>
<TOKEN end_char="841" id="token-2-52" morph="none" pos="word" start_char="830">bamlanivimab</TOKEN>
<TOKEN end_char="842" id="token-2-53" morph="none" pos="punct" start_char="842">,</TOKEN>
<TOKEN end_char="849" id="token-2-54" morph="none" pos="word" start_char="844">cuando</TOKEN>
<TOKEN end_char="852" id="token-2-55" morph="none" pos="word" start_char="851">se</TOKEN>
<TOKEN end_char="863" id="token-2-56" morph="none" pos="word" start_char="854">administra</TOKEN>
<TOKEN end_char="868" id="token-2-57" morph="none" pos="word" start_char="865">solo</TOKEN>
<TOKEN end_char="869" id="token-2-58" morph="none" pos="punct" start_char="869">,</TOKEN>
<TOKEN end_char="872" id="token-2-59" morph="none" pos="word" start_char="871">ya</TOKEN>
<TOKEN end_char="875" id="token-2-60" morph="none" pos="word" start_char="874">no</TOKEN>
<TOKEN end_char="883" id="token-2-61" morph="none" pos="word" start_char="877">superan</TOKEN>
<TOKEN end_char="887" id="token-2-62" morph="none" pos="word" start_char="885">los</TOKEN>
<TOKEN end_char="895" id="token-2-63" morph="none" pos="word" start_char="889">riesgos</TOKEN>
<TOKEN end_char="905" id="token-2-64" morph="none" pos="word" start_char="897">conocidos</TOKEN>
<TOKEN end_char="907" id="token-2-65" morph="none" pos="word" start_char="907">y</TOKEN>
<TOKEN end_char="919" id="token-2-66" morph="none" pos="word" start_char="909">potenciales</TOKEN>
<TOKEN end_char="924" id="token-2-67" morph="none" pos="word" start_char="921">para</TOKEN>
<TOKEN end_char="927" id="token-2-68" morph="none" pos="word" start_char="926">su</TOKEN>
<TOKEN end_char="931" id="token-2-69" morph="none" pos="word" start_char="929">uso</TOKEN>
<TOKEN end_char="942" id="token-2-70" morph="none" pos="word" start_char="933">autorizado</TOKEN>
<TOKEN end_char="943" id="token-2-71" morph="none" pos="punct" start_char="943">.</TOKEN>
<TRANSLATED_TEXT>Based on its ongoing analysis of emerging scientific data, specifically the sustained increase in viral variants of SARS-CoV-2 that are resistant to bamlanivimab alone, resulting in an increased risk of treatment failure, the FDA has determined that the known and potential benefits of bamlanivimab, when administered alone, no longer exceed the known and potential risks for its authorized use.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1071" id="segment-3" start_char="945">
<ORIGINAL_TEXT>Por lo tanto, la agencia determinó que ya no se cumplen los criterios para la emisión de una autorización y ha revocado la EUA.</ORIGINAL_TEXT>
<TOKEN end_char="947" id="token-3-0" morph="none" pos="word" start_char="945">Por</TOKEN>
<TOKEN end_char="950" id="token-3-1" morph="none" pos="word" start_char="949">lo</TOKEN>
<TOKEN end_char="956" id="token-3-2" morph="none" pos="word" start_char="952">tanto</TOKEN>
<TOKEN end_char="957" id="token-3-3" morph="none" pos="punct" start_char="957">,</TOKEN>
<TOKEN end_char="960" id="token-3-4" morph="none" pos="word" start_char="959">la</TOKEN>
<TOKEN end_char="968" id="token-3-5" morph="none" pos="word" start_char="962">agencia</TOKEN>
<TOKEN end_char="978" id="token-3-6" morph="none" pos="word" start_char="970">determinó</TOKEN>
<TOKEN end_char="982" id="token-3-7" morph="none" pos="word" start_char="980">que</TOKEN>
<TOKEN end_char="985" id="token-3-8" morph="none" pos="word" start_char="984">ya</TOKEN>
<TOKEN end_char="988" id="token-3-9" morph="none" pos="word" start_char="987">no</TOKEN>
<TOKEN end_char="991" id="token-3-10" morph="none" pos="word" start_char="990">se</TOKEN>
<TOKEN end_char="999" id="token-3-11" morph="none" pos="word" start_char="993">cumplen</TOKEN>
<TOKEN end_char="1003" id="token-3-12" morph="none" pos="word" start_char="1001">los</TOKEN>
<TOKEN end_char="1013" id="token-3-13" morph="none" pos="word" start_char="1005">criterios</TOKEN>
<TOKEN end_char="1018" id="token-3-14" morph="none" pos="word" start_char="1015">para</TOKEN>
<TOKEN end_char="1021" id="token-3-15" morph="none" pos="word" start_char="1020">la</TOKEN>
<TOKEN end_char="1029" id="token-3-16" morph="none" pos="word" start_char="1023">emisión</TOKEN>
<TOKEN end_char="1032" id="token-3-17" morph="none" pos="word" start_char="1031">de</TOKEN>
<TOKEN end_char="1036" id="token-3-18" morph="none" pos="word" start_char="1034">una</TOKEN>
<TOKEN end_char="1049" id="token-3-19" morph="none" pos="word" start_char="1038">autorización</TOKEN>
<TOKEN end_char="1051" id="token-3-20" morph="none" pos="word" start_char="1051">y</TOKEN>
<TOKEN end_char="1054" id="token-3-21" morph="none" pos="word" start_char="1053">ha</TOKEN>
<TOKEN end_char="1063" id="token-3-22" morph="none" pos="word" start_char="1056">revocado</TOKEN>
<TOKEN end_char="1066" id="token-3-23" morph="none" pos="word" start_char="1065">la</TOKEN>
<TOKEN end_char="1070" id="token-3-24" morph="none" pos="word" start_char="1068">EUA</TOKEN>
<TOKEN end_char="1071" id="token-3-25" morph="none" pos="punct" start_char="1071">.</TOKEN>
<TRANSLATED_TEXT>Therefore, the agency determined that the criteria for issuing an authorization were no longer met and has revoked the US.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1222" id="segment-4" start_char="1074">
<ORIGINAL_TEXT>El 9 de noviembre de 2020, basándose en la totalidad de las pruebas científicas disponibles en ese momento, la FDA emitió una EUA a Eli Lilly and Co.</ORIGINAL_TEXT>
<TOKEN end_char="1075" id="token-4-0" morph="none" pos="word" start_char="1074">El</TOKEN>
<TOKEN end_char="1077" id="token-4-1" morph="none" pos="word" start_char="1077">9</TOKEN>
<TOKEN end_char="1080" id="token-4-2" morph="none" pos="word" start_char="1079">de</TOKEN>
<TOKEN end_char="1090" id="token-4-3" morph="none" pos="word" start_char="1082">noviembre</TOKEN>
<TOKEN end_char="1093" id="token-4-4" morph="none" pos="word" start_char="1092">de</TOKEN>
<TOKEN end_char="1098" id="token-4-5" morph="none" pos="word" start_char="1095">2020</TOKEN>
<TOKEN end_char="1099" id="token-4-6" morph="none" pos="punct" start_char="1099">,</TOKEN>
<TOKEN end_char="1109" id="token-4-7" morph="none" pos="word" start_char="1101">basándose</TOKEN>
<TOKEN end_char="1112" id="token-4-8" morph="none" pos="word" start_char="1111">en</TOKEN>
<TOKEN end_char="1115" id="token-4-9" morph="none" pos="word" start_char="1114">la</TOKEN>
<TOKEN end_char="1125" id="token-4-10" morph="none" pos="word" start_char="1117">totalidad</TOKEN>
<TOKEN end_char="1128" id="token-4-11" morph="none" pos="word" start_char="1127">de</TOKEN>
<TOKEN end_char="1132" id="token-4-12" morph="none" pos="word" start_char="1130">las</TOKEN>
<TOKEN end_char="1140" id="token-4-13" morph="none" pos="word" start_char="1134">pruebas</TOKEN>
<TOKEN end_char="1152" id="token-4-14" morph="none" pos="word" start_char="1142">científicas</TOKEN>
<TOKEN end_char="1164" id="token-4-15" morph="none" pos="word" start_char="1154">disponibles</TOKEN>
<TOKEN end_char="1167" id="token-4-16" morph="none" pos="word" start_char="1166">en</TOKEN>
<TOKEN end_char="1171" id="token-4-17" morph="none" pos="word" start_char="1169">ese</TOKEN>
<TOKEN end_char="1179" id="token-4-18" morph="none" pos="word" start_char="1173">momento</TOKEN>
<TOKEN end_char="1180" id="token-4-19" morph="none" pos="punct" start_char="1180">,</TOKEN>
<TOKEN end_char="1183" id="token-4-20" morph="none" pos="word" start_char="1182">la</TOKEN>
<TOKEN end_char="1187" id="token-4-21" morph="none" pos="word" start_char="1185">FDA</TOKEN>
<TOKEN end_char="1194" id="token-4-22" morph="none" pos="word" start_char="1189">emitió</TOKEN>
<TOKEN end_char="1198" id="token-4-23" morph="none" pos="word" start_char="1196">una</TOKEN>
<TOKEN end_char="1202" id="token-4-24" morph="none" pos="word" start_char="1200">EUA</TOKEN>
<TOKEN end_char="1204" id="token-4-25" morph="none" pos="word" start_char="1204">a</TOKEN>
<TOKEN end_char="1208" id="token-4-26" morph="none" pos="word" start_char="1206">Eli</TOKEN>
<TOKEN end_char="1214" id="token-4-27" morph="none" pos="word" start_char="1210">Lilly</TOKEN>
<TOKEN end_char="1218" id="token-4-28" morph="none" pos="word" start_char="1216">and</TOKEN>
<TOKEN end_char="1221" id="token-4-29" morph="none" pos="word" start_char="1220">Co</TOKEN>
<TOKEN end_char="1222" id="token-4-30" morph="none" pos="punct" start_char="1222">.</TOKEN>
<TRANSLATED_TEXT>On November 9, 2020, based on all available scientific evidence at the time, the FDA issued a U.S. patent to Eli Lilly and Co.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1564" id="segment-5" start_char="1224">
<ORIGINAL_TEXT>autorizando el uso de emergencia de bamlanivimab solo para el tratamiento del COVID-19 de leve a moderado en adultos y pacientes pediátricos (de 12 años o más que pesen al menos 40 kg) con resultados positivos en las pruebas virales directas del SARS-CoV-2, y que están en alto riesgo de progresar al COVID-19 grave y/o a la hospitalización.</ORIGINAL_TEXT>
<TOKEN end_char="1234" id="token-5-0" morph="none" pos="word" start_char="1224">autorizando</TOKEN>
<TOKEN end_char="1237" id="token-5-1" morph="none" pos="word" start_char="1236">el</TOKEN>
<TOKEN end_char="1241" id="token-5-2" morph="none" pos="word" start_char="1239">uso</TOKEN>
<TOKEN end_char="1244" id="token-5-3" morph="none" pos="word" start_char="1243">de</TOKEN>
<TOKEN end_char="1255" id="token-5-4" morph="none" pos="word" start_char="1246">emergencia</TOKEN>
<TOKEN end_char="1258" id="token-5-5" morph="none" pos="word" start_char="1257">de</TOKEN>
<TOKEN end_char="1271" id="token-5-6" morph="none" pos="word" start_char="1260">bamlanivimab</TOKEN>
<TOKEN end_char="1276" id="token-5-7" morph="none" pos="word" start_char="1273">solo</TOKEN>
<TOKEN end_char="1281" id="token-5-8" morph="none" pos="word" start_char="1278">para</TOKEN>
<TOKEN end_char="1284" id="token-5-9" morph="none" pos="word" start_char="1283">el</TOKEN>
<TOKEN end_char="1296" id="token-5-10" morph="none" pos="word" start_char="1286">tratamiento</TOKEN>
<TOKEN end_char="1300" id="token-5-11" morph="none" pos="word" start_char="1298">del</TOKEN>
<TOKEN end_char="1309" id="token-5-12" morph="none" pos="unknown" start_char="1302">COVID-19</TOKEN>
<TOKEN end_char="1312" id="token-5-13" morph="none" pos="word" start_char="1311">de</TOKEN>
<TOKEN end_char="1317" id="token-5-14" morph="none" pos="word" start_char="1314">leve</TOKEN>
<TOKEN end_char="1319" id="token-5-15" morph="none" pos="word" start_char="1319">a</TOKEN>
<TOKEN end_char="1328" id="token-5-16" morph="none" pos="word" start_char="1321">moderado</TOKEN>
<TOKEN end_char="1331" id="token-5-17" morph="none" pos="word" start_char="1330">en</TOKEN>
<TOKEN end_char="1339" id="token-5-18" morph="none" pos="word" start_char="1333">adultos</TOKEN>
<TOKEN end_char="1341" id="token-5-19" morph="none" pos="word" start_char="1341">y</TOKEN>
<TOKEN end_char="1351" id="token-5-20" morph="none" pos="word" start_char="1343">pacientes</TOKEN>
<TOKEN end_char="1363" id="token-5-21" morph="none" pos="word" start_char="1353">pediátricos</TOKEN>
<TOKEN end_char="1365" id="token-5-22" morph="none" pos="punct" start_char="1365">(</TOKEN>
<TOKEN end_char="1367" id="token-5-23" morph="none" pos="word" start_char="1366">de</TOKEN>
<TOKEN end_char="1370" id="token-5-24" morph="none" pos="word" start_char="1369">12</TOKEN>
<TOKEN end_char="1375" id="token-5-25" morph="none" pos="word" start_char="1372">años</TOKEN>
<TOKEN end_char="1377" id="token-5-26" morph="none" pos="word" start_char="1377">o</TOKEN>
<TOKEN end_char="1381" id="token-5-27" morph="none" pos="word" start_char="1379">más</TOKEN>
<TOKEN end_char="1385" id="token-5-28" morph="none" pos="word" start_char="1383">que</TOKEN>
<TOKEN end_char="1391" id="token-5-29" morph="none" pos="word" start_char="1387">pesen</TOKEN>
<TOKEN end_char="1394" id="token-5-30" morph="none" pos="word" start_char="1393">al</TOKEN>
<TOKEN end_char="1400" id="token-5-31" morph="none" pos="word" start_char="1396">menos</TOKEN>
<TOKEN end_char="1403" id="token-5-32" morph="none" pos="word" start_char="1402">40</TOKEN>
<TOKEN end_char="1406" id="token-5-33" morph="none" pos="word" start_char="1405">kg</TOKEN>
<TOKEN end_char="1407" id="token-5-34" morph="none" pos="punct" start_char="1407">)</TOKEN>
<TOKEN end_char="1411" id="token-5-35" morph="none" pos="word" start_char="1409">con</TOKEN>
<TOKEN end_char="1422" id="token-5-36" morph="none" pos="word" start_char="1413">resultados</TOKEN>
<TOKEN end_char="1432" id="token-5-37" morph="none" pos="word" start_char="1424">positivos</TOKEN>
<TOKEN end_char="1435" id="token-5-38" morph="none" pos="word" start_char="1434">en</TOKEN>
<TOKEN end_char="1439" id="token-5-39" morph="none" pos="word" start_char="1437">las</TOKEN>
<TOKEN end_char="1447" id="token-5-40" morph="none" pos="word" start_char="1441">pruebas</TOKEN>
<TOKEN end_char="1455" id="token-5-41" morph="none" pos="word" start_char="1449">virales</TOKEN>
<TOKEN end_char="1464" id="token-5-42" morph="none" pos="word" start_char="1457">directas</TOKEN>
<TOKEN end_char="1468" id="token-5-43" morph="none" pos="word" start_char="1466">del</TOKEN>
<TOKEN end_char="1479" id="token-5-44" morph="none" pos="unknown" start_char="1470">SARS-CoV-2</TOKEN>
<TOKEN end_char="1480" id="token-5-45" morph="none" pos="punct" start_char="1480">,</TOKEN>
<TOKEN end_char="1482" id="token-5-46" morph="none" pos="word" start_char="1482">y</TOKEN>
<TOKEN end_char="1486" id="token-5-47" morph="none" pos="word" start_char="1484">que</TOKEN>
<TOKEN end_char="1492" id="token-5-48" morph="none" pos="word" start_char="1488">están</TOKEN>
<TOKEN end_char="1495" id="token-5-49" morph="none" pos="word" start_char="1494">en</TOKEN>
<TOKEN end_char="1500" id="token-5-50" morph="none" pos="word" start_char="1497">alto</TOKEN>
<TOKEN end_char="1507" id="token-5-51" morph="none" pos="word" start_char="1502">riesgo</TOKEN>
<TOKEN end_char="1510" id="token-5-52" morph="none" pos="word" start_char="1509">de</TOKEN>
<TOKEN end_char="1520" id="token-5-53" morph="none" pos="word" start_char="1512">progresar</TOKEN>
<TOKEN end_char="1523" id="token-5-54" morph="none" pos="word" start_char="1522">al</TOKEN>
<TOKEN end_char="1532" id="token-5-55" morph="none" pos="unknown" start_char="1525">COVID-19</TOKEN>
<TOKEN end_char="1538" id="token-5-56" morph="none" pos="word" start_char="1534">grave</TOKEN>
<TOKEN end_char="1542" id="token-5-57" morph="none" pos="unknown" start_char="1540">y/o</TOKEN>
<TOKEN end_char="1544" id="token-5-58" morph="none" pos="word" start_char="1544">a</TOKEN>
<TOKEN end_char="1547" id="token-5-59" morph="none" pos="word" start_char="1546">la</TOKEN>
<TOKEN end_char="1563" id="token-5-60" morph="none" pos="word" start_char="1549">hospitalización</TOKEN>
<TOKEN end_char="1564" id="token-5-61" morph="none" pos="punct" start_char="1564">.</TOKEN>
<TRANSLATED_TEXT>authorizing the emergency use of bamlanivimab only for the treatment of mild to moderate COVID-19 in adults and paediatric patients (aged 12 years or over weighing at least 40 kg) with positive results in direct viral tests of SARS-CoV-2, and who are at high risk of progression to severe COVID-19 and / or hospitalization.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1945" id="segment-6" start_char="1566">
<ORIGINAL_TEXT>Es importante destacar que, aunque la FDA está revocando ahora esta EUA, las terapias alternativas de anticuerpos monoclonales siguen estando disponibles bajo la EUA, incluyendo REGEN-COV (casirivimab y imdevimab, administrados juntos) (en inglés), y bamlanivimab y etesevimab, administrados juntos (en inglés), para los mismos usos autorizados previamente para bamlanivimab solo.</ORIGINAL_TEXT>
<TOKEN end_char="1567" id="token-6-0" morph="none" pos="word" start_char="1566">Es</TOKEN>
<TOKEN end_char="1578" id="token-6-1" morph="none" pos="word" start_char="1569">importante</TOKEN>
<TOKEN end_char="1587" id="token-6-2" morph="none" pos="word" start_char="1580">destacar</TOKEN>
<TOKEN end_char="1591" id="token-6-3" morph="none" pos="word" start_char="1589">que</TOKEN>
<TOKEN end_char="1592" id="token-6-4" morph="none" pos="punct" start_char="1592">,</TOKEN>
<TOKEN end_char="1599" id="token-6-5" morph="none" pos="word" start_char="1594">aunque</TOKEN>
<TOKEN end_char="1602" id="token-6-6" morph="none" pos="word" start_char="1601">la</TOKEN>
<TOKEN end_char="1606" id="token-6-7" morph="none" pos="word" start_char="1604">FDA</TOKEN>
<TOKEN end_char="1611" id="token-6-8" morph="none" pos="word" start_char="1608">está</TOKEN>
<TOKEN end_char="1621" id="token-6-9" morph="none" pos="word" start_char="1613">revocando</TOKEN>
<TOKEN end_char="1627" id="token-6-10" morph="none" pos="word" start_char="1623">ahora</TOKEN>
<TOKEN end_char="1632" id="token-6-11" morph="none" pos="word" start_char="1629">esta</TOKEN>
<TOKEN end_char="1636" id="token-6-12" morph="none" pos="word" start_char="1634">EUA</TOKEN>
<TOKEN end_char="1637" id="token-6-13" morph="none" pos="punct" start_char="1637">,</TOKEN>
<TOKEN end_char="1641" id="token-6-14" morph="none" pos="word" start_char="1639">las</TOKEN>
<TOKEN end_char="1650" id="token-6-15" morph="none" pos="word" start_char="1643">terapias</TOKEN>
<TOKEN end_char="1663" id="token-6-16" morph="none" pos="word" start_char="1652">alternativas</TOKEN>
<TOKEN end_char="1666" id="token-6-17" morph="none" pos="word" start_char="1665">de</TOKEN>
<TOKEN end_char="1678" id="token-6-18" morph="none" pos="word" start_char="1668">anticuerpos</TOKEN>
<TOKEN end_char="1691" id="token-6-19" morph="none" pos="word" start_char="1680">monoclonales</TOKEN>
<TOKEN end_char="1698" id="token-6-20" morph="none" pos="word" start_char="1693">siguen</TOKEN>
<TOKEN end_char="1706" id="token-6-21" morph="none" pos="word" start_char="1700">estando</TOKEN>
<TOKEN end_char="1718" id="token-6-22" morph="none" pos="word" start_char="1708">disponibles</TOKEN>
<TOKEN end_char="1723" id="token-6-23" morph="none" pos="word" start_char="1720">bajo</TOKEN>
<TOKEN end_char="1726" id="token-6-24" morph="none" pos="word" start_char="1725">la</TOKEN>
<TOKEN end_char="1730" id="token-6-25" morph="none" pos="word" start_char="1728">EUA</TOKEN>
<TOKEN end_char="1731" id="token-6-26" morph="none" pos="punct" start_char="1731">,</TOKEN>
<TOKEN end_char="1742" id="token-6-27" morph="none" pos="word" start_char="1733">incluyendo</TOKEN>
<TOKEN end_char="1752" id="token-6-28" morph="none" pos="unknown" start_char="1744">REGEN-COV</TOKEN>
<TOKEN end_char="1754" id="token-6-29" morph="none" pos="punct" start_char="1754">(</TOKEN>
<TOKEN end_char="1765" id="token-6-30" morph="none" pos="word" start_char="1755">casirivimab</TOKEN>
<TOKEN end_char="1767" id="token-6-31" morph="none" pos="word" start_char="1767">y</TOKEN>
<TOKEN end_char="1777" id="token-6-32" morph="none" pos="word" start_char="1769">imdevimab</TOKEN>
<TOKEN end_char="1778" id="token-6-33" morph="none" pos="punct" start_char="1778">,</TOKEN>
<TOKEN end_char="1792" id="token-6-34" morph="none" pos="word" start_char="1780">administrados</TOKEN>
<TOKEN end_char="1799" id="token-6-35" morph="none" pos="word" start_char="1794">juntos</TOKEN>
<TOKEN end_char="1800" id="token-6-36" morph="none" pos="punct" start_char="1800">)</TOKEN>
<TOKEN end_char="1802" id="token-6-37" morph="none" pos="punct" start_char="1802">(</TOKEN>
<TOKEN end_char="1804" id="token-6-38" morph="none" pos="word" start_char="1803">en</TOKEN>
<TOKEN end_char="1811" id="token-6-39" morph="none" pos="word" start_char="1806">inglés</TOKEN>
<TOKEN end_char="1813" id="token-6-40" morph="none" pos="punct" start_char="1812">),</TOKEN>
<TOKEN end_char="1815" id="token-6-41" morph="none" pos="word" start_char="1815">y</TOKEN>
<TOKEN end_char="1828" id="token-6-42" morph="none" pos="word" start_char="1817">bamlanivimab</TOKEN>
<TOKEN end_char="1830" id="token-6-43" morph="none" pos="word" start_char="1830">y</TOKEN>
<TOKEN end_char="1841" id="token-6-44" morph="none" pos="word" start_char="1832">etesevimab</TOKEN>
<TOKEN end_char="1842" id="token-6-45" morph="none" pos="punct" start_char="1842">,</TOKEN>
<TOKEN end_char="1856" id="token-6-46" morph="none" pos="word" start_char="1844">administrados</TOKEN>
<TOKEN end_char="1863" id="token-6-47" morph="none" pos="word" start_char="1858">juntos</TOKEN>
<TOKEN end_char="1865" id="token-6-48" morph="none" pos="punct" start_char="1865">(</TOKEN>
<TOKEN end_char="1867" id="token-6-49" morph="none" pos="word" start_char="1866">en</TOKEN>
<TOKEN end_char="1874" id="token-6-50" morph="none" pos="word" start_char="1869">inglés</TOKEN>
<TOKEN end_char="1876" id="token-6-51" morph="none" pos="punct" start_char="1875">),</TOKEN>
<TOKEN end_char="1881" id="token-6-52" morph="none" pos="word" start_char="1878">para</TOKEN>
<TOKEN end_char="1885" id="token-6-53" morph="none" pos="word" start_char="1883">los</TOKEN>
<TOKEN end_char="1892" id="token-6-54" morph="none" pos="word" start_char="1887">mismos</TOKEN>
<TOKEN end_char="1897" id="token-6-55" morph="none" pos="word" start_char="1894">usos</TOKEN>
<TOKEN end_char="1909" id="token-6-56" morph="none" pos="word" start_char="1899">autorizados</TOKEN>
<TOKEN end_char="1921" id="token-6-57" morph="none" pos="word" start_char="1911">previamente</TOKEN>
<TOKEN end_char="1926" id="token-6-58" morph="none" pos="word" start_char="1923">para</TOKEN>
<TOKEN end_char="1939" id="token-6-59" morph="none" pos="word" start_char="1928">bamlanivimab</TOKEN>
<TOKEN end_char="1944" id="token-6-60" morph="none" pos="word" start_char="1941">solo</TOKEN>
<TOKEN end_char="1945" id="token-6-61" morph="none" pos="punct" start_char="1945">.</TOKEN>
<TRANSLATED_TEXT>It is important to note that, although the FDA is now revoking this US, alternative monoclonal antibody therapies are still available under the US, including REGEN-COV (casirivimab and imdevimab, administered together), and bamlanivimab and eteselab, administered together, for the same uses previously authorized for bamlanivimab alone.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2211" id="segment-7" start_char="1947">
<ORIGINAL_TEXT>La FDA considera que estas terapias alternativas de anticuerpos monoclonales siguen siendo apropiadas para tratar a los pacientes con el COVID-19 cuando se utilizan de acuerdo con las indicaciones autorizadas, basándose en la información disponible en este momento.</ORIGINAL_TEXT>
<TOKEN end_char="1948" id="token-7-0" morph="none" pos="word" start_char="1947">La</TOKEN>
<TOKEN end_char="1952" id="token-7-1" morph="none" pos="word" start_char="1950">FDA</TOKEN>
<TOKEN end_char="1962" id="token-7-2" morph="none" pos="word" start_char="1954">considera</TOKEN>
<TOKEN end_char="1966" id="token-7-3" morph="none" pos="word" start_char="1964">que</TOKEN>
<TOKEN end_char="1972" id="token-7-4" morph="none" pos="word" start_char="1968">estas</TOKEN>
<TOKEN end_char="1981" id="token-7-5" morph="none" pos="word" start_char="1974">terapias</TOKEN>
<TOKEN end_char="1994" id="token-7-6" morph="none" pos="word" start_char="1983">alternativas</TOKEN>
<TOKEN end_char="1997" id="token-7-7" morph="none" pos="word" start_char="1996">de</TOKEN>
<TOKEN end_char="2009" id="token-7-8" morph="none" pos="word" start_char="1999">anticuerpos</TOKEN>
<TOKEN end_char="2022" id="token-7-9" morph="none" pos="word" start_char="2011">monoclonales</TOKEN>
<TOKEN end_char="2029" id="token-7-10" morph="none" pos="word" start_char="2024">siguen</TOKEN>
<TOKEN end_char="2036" id="token-7-11" morph="none" pos="word" start_char="2031">siendo</TOKEN>
<TOKEN end_char="2047" id="token-7-12" morph="none" pos="word" start_char="2038">apropiadas</TOKEN>
<TOKEN end_char="2052" id="token-7-13" morph="none" pos="word" start_char="2049">para</TOKEN>
<TOKEN end_char="2059" id="token-7-14" morph="none" pos="word" start_char="2054">tratar</TOKEN>
<TOKEN end_char="2061" id="token-7-15" morph="none" pos="word" start_char="2061">a</TOKEN>
<TOKEN end_char="2065" id="token-7-16" morph="none" pos="word" start_char="2063">los</TOKEN>
<TOKEN end_char="2075" id="token-7-17" morph="none" pos="word" start_char="2067">pacientes</TOKEN>
<TOKEN end_char="2079" id="token-7-18" morph="none" pos="word" start_char="2077">con</TOKEN>
<TOKEN end_char="2082" id="token-7-19" morph="none" pos="word" start_char="2081">el</TOKEN>
<TOKEN end_char="2091" id="token-7-20" morph="none" pos="unknown" start_char="2084">COVID-19</TOKEN>
<TOKEN end_char="2098" id="token-7-21" morph="none" pos="word" start_char="2093">cuando</TOKEN>
<TOKEN end_char="2101" id="token-7-22" morph="none" pos="word" start_char="2100">se</TOKEN>
<TOKEN end_char="2110" id="token-7-23" morph="none" pos="word" start_char="2103">utilizan</TOKEN>
<TOKEN end_char="2113" id="token-7-24" morph="none" pos="word" start_char="2112">de</TOKEN>
<TOKEN end_char="2121" id="token-7-25" morph="none" pos="word" start_char="2115">acuerdo</TOKEN>
<TOKEN end_char="2125" id="token-7-26" morph="none" pos="word" start_char="2123">con</TOKEN>
<TOKEN end_char="2129" id="token-7-27" morph="none" pos="word" start_char="2127">las</TOKEN>
<TOKEN end_char="2142" id="token-7-28" morph="none" pos="word" start_char="2131">indicaciones</TOKEN>
<TOKEN end_char="2154" id="token-7-29" morph="none" pos="word" start_char="2144">autorizadas</TOKEN>
<TOKEN end_char="2155" id="token-7-30" morph="none" pos="punct" start_char="2155">,</TOKEN>
<TOKEN end_char="2165" id="token-7-31" morph="none" pos="word" start_char="2157">basándose</TOKEN>
<TOKEN end_char="2168" id="token-7-32" morph="none" pos="word" start_char="2167">en</TOKEN>
<TOKEN end_char="2171" id="token-7-33" morph="none" pos="word" start_char="2170">la</TOKEN>
<TOKEN end_char="2183" id="token-7-34" morph="none" pos="word" start_char="2173">información</TOKEN>
<TOKEN end_char="2194" id="token-7-35" morph="none" pos="word" start_char="2185">disponible</TOKEN>
<TOKEN end_char="2197" id="token-7-36" morph="none" pos="word" start_char="2196">en</TOKEN>
<TOKEN end_char="2202" id="token-7-37" morph="none" pos="word" start_char="2199">este</TOKEN>
<TOKEN end_char="2210" id="token-7-38" morph="none" pos="word" start_char="2204">momento</TOKEN>
<TOKEN end_char="2211" id="token-7-39" morph="none" pos="punct" start_char="2211">.</TOKEN>
<TRANSLATED_TEXT>The FDA considers that these alternative monoclonal antibody therapies remain appropriate to treat patients with COVID-19 when used according to authorized indications, based on the information currently available.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2773" id="segment-8" start_char="2214">
<ORIGINAL_TEXT>"Si bien la evaluación de riesgo-beneficio para el uso de bamlanivimab solo ya no es favorable debido al aumento de la frecuencia de variantes resistentes, otras terapias de anticuerpos monoclonales autorizadas para uso de emergencia siguen siendo opciones de tratamiento apropiadas cuando se utilizan de acuerdo con las indicaciones autorizadas y pueden ayudar a mantener a los pacientes de alto riesgo con el COVID-19 fuera del hospital", dijo la doctora Patrizia Cavazzoni, M.D., directora del Centro de Evaluación e Investigación de Medicamentos de la FDA.</ORIGINAL_TEXT>
<TOKEN end_char="2214" id="token-8-0" morph="none" pos="punct" start_char="2214">"</TOKEN>
<TOKEN end_char="2216" id="token-8-1" morph="none" pos="word" start_char="2215">Si</TOKEN>
<TOKEN end_char="2221" id="token-8-2" morph="none" pos="word" start_char="2218">bien</TOKEN>
<TOKEN end_char="2224" id="token-8-3" morph="none" pos="word" start_char="2223">la</TOKEN>
<TOKEN end_char="2235" id="token-8-4" morph="none" pos="word" start_char="2226">evaluación</TOKEN>
<TOKEN end_char="2238" id="token-8-5" morph="none" pos="word" start_char="2237">de</TOKEN>
<TOKEN end_char="2255" id="token-8-6" morph="none" pos="unknown" start_char="2240">riesgo-beneficio</TOKEN>
<TOKEN end_char="2260" id="token-8-7" morph="none" pos="word" start_char="2257">para</TOKEN>
<TOKEN end_char="2263" id="token-8-8" morph="none" pos="word" start_char="2262">el</TOKEN>
<TOKEN end_char="2267" id="token-8-9" morph="none" pos="word" start_char="2265">uso</TOKEN>
<TOKEN end_char="2270" id="token-8-10" morph="none" pos="word" start_char="2269">de</TOKEN>
<TOKEN end_char="2283" id="token-8-11" morph="none" pos="word" start_char="2272">bamlanivimab</TOKEN>
<TOKEN end_char="2288" id="token-8-12" morph="none" pos="word" start_char="2285">solo</TOKEN>
<TOKEN end_char="2291" id="token-8-13" morph="none" pos="word" start_char="2290">ya</TOKEN>
<TOKEN end_char="2294" id="token-8-14" morph="none" pos="word" start_char="2293">no</TOKEN>
<TOKEN end_char="2297" id="token-8-15" morph="none" pos="word" start_char="2296">es</TOKEN>
<TOKEN end_char="2307" id="token-8-16" morph="none" pos="word" start_char="2299">favorable</TOKEN>
<TOKEN end_char="2314" id="token-8-17" morph="none" pos="word" start_char="2309">debido</TOKEN>
<TOKEN end_char="2317" id="token-8-18" morph="none" pos="word" start_char="2316">al</TOKEN>
<TOKEN end_char="2325" id="token-8-19" morph="none" pos="word" start_char="2319">aumento</TOKEN>
<TOKEN end_char="2328" id="token-8-20" morph="none" pos="word" start_char="2327">de</TOKEN>
<TOKEN end_char="2331" id="token-8-21" morph="none" pos="word" start_char="2330">la</TOKEN>
<TOKEN end_char="2342" id="token-8-22" morph="none" pos="word" start_char="2333">frecuencia</TOKEN>
<TOKEN end_char="2345" id="token-8-23" morph="none" pos="word" start_char="2344">de</TOKEN>
<TOKEN end_char="2355" id="token-8-24" morph="none" pos="word" start_char="2347">variantes</TOKEN>
<TOKEN end_char="2367" id="token-8-25" morph="none" pos="word" start_char="2357">resistentes</TOKEN>
<TOKEN end_char="2368" id="token-8-26" morph="none" pos="punct" start_char="2368">,</TOKEN>
<TOKEN end_char="2374" id="token-8-27" morph="none" pos="word" start_char="2370">otras</TOKEN>
<TOKEN end_char="2383" id="token-8-28" morph="none" pos="word" start_char="2376">terapias</TOKEN>
<TOKEN end_char="2386" id="token-8-29" morph="none" pos="word" start_char="2385">de</TOKEN>
<TOKEN end_char="2398" id="token-8-30" morph="none" pos="word" start_char="2388">anticuerpos</TOKEN>
<TOKEN end_char="2411" id="token-8-31" morph="none" pos="word" start_char="2400">monoclonales</TOKEN>
<TOKEN end_char="2423" id="token-8-32" morph="none" pos="word" start_char="2413">autorizadas</TOKEN>
<TOKEN end_char="2428" id="token-8-33" morph="none" pos="word" start_char="2425">para</TOKEN>
<TOKEN end_char="2432" id="token-8-34" morph="none" pos="word" start_char="2430">uso</TOKEN>
<TOKEN end_char="2435" id="token-8-35" morph="none" pos="word" start_char="2434">de</TOKEN>
<TOKEN end_char="2446" id="token-8-36" morph="none" pos="word" start_char="2437">emergencia</TOKEN>
<TOKEN end_char="2453" id="token-8-37" morph="none" pos="word" start_char="2448">siguen</TOKEN>
<TOKEN end_char="2460" id="token-8-38" morph="none" pos="word" start_char="2455">siendo</TOKEN>
<TOKEN end_char="2469" id="token-8-39" morph="none" pos="word" start_char="2462">opciones</TOKEN>
<TOKEN end_char="2472" id="token-8-40" morph="none" pos="word" start_char="2471">de</TOKEN>
<TOKEN end_char="2484" id="token-8-41" morph="none" pos="word" start_char="2474">tratamiento</TOKEN>
<TOKEN end_char="2495" id="token-8-42" morph="none" pos="word" start_char="2486">apropiadas</TOKEN>
<TOKEN end_char="2502" id="token-8-43" morph="none" pos="word" start_char="2497">cuando</TOKEN>
<TOKEN end_char="2505" id="token-8-44" morph="none" pos="word" start_char="2504">se</TOKEN>
<TOKEN end_char="2514" id="token-8-45" morph="none" pos="word" start_char="2507">utilizan</TOKEN>
<TOKEN end_char="2517" id="token-8-46" morph="none" pos="word" start_char="2516">de</TOKEN>
<TOKEN end_char="2525" id="token-8-47" morph="none" pos="word" start_char="2519">acuerdo</TOKEN>
<TOKEN end_char="2529" id="token-8-48" morph="none" pos="word" start_char="2527">con</TOKEN>
<TOKEN end_char="2533" id="token-8-49" morph="none" pos="word" start_char="2531">las</TOKEN>
<TOKEN end_char="2546" id="token-8-50" morph="none" pos="word" start_char="2535">indicaciones</TOKEN>
<TOKEN end_char="2558" id="token-8-51" morph="none" pos="word" start_char="2548">autorizadas</TOKEN>
<TOKEN end_char="2560" id="token-8-52" morph="none" pos="word" start_char="2560">y</TOKEN>
<TOKEN end_char="2567" id="token-8-53" morph="none" pos="word" start_char="2562">pueden</TOKEN>
<TOKEN end_char="2574" id="token-8-54" morph="none" pos="word" start_char="2569">ayudar</TOKEN>
<TOKEN end_char="2576" id="token-8-55" morph="none" pos="word" start_char="2576">a</TOKEN>
<TOKEN end_char="2585" id="token-8-56" morph="none" pos="word" start_char="2578">mantener</TOKEN>
<TOKEN end_char="2587" id="token-8-57" morph="none" pos="word" start_char="2587">a</TOKEN>
<TOKEN end_char="2591" id="token-8-58" morph="none" pos="word" start_char="2589">los</TOKEN>
<TOKEN end_char="2601" id="token-8-59" morph="none" pos="word" start_char="2593">pacientes</TOKEN>
<TOKEN end_char="2604" id="token-8-60" morph="none" pos="word" start_char="2603">de</TOKEN>
<TOKEN end_char="2609" id="token-8-61" morph="none" pos="word" start_char="2606">alto</TOKEN>
<TOKEN end_char="2616" id="token-8-62" morph="none" pos="word" start_char="2611">riesgo</TOKEN>
<TOKEN end_char="2620" id="token-8-63" morph="none" pos="word" start_char="2618">con</TOKEN>
<TOKEN end_char="2623" id="token-8-64" morph="none" pos="word" start_char="2622">el</TOKEN>
<TOKEN end_char="2632" id="token-8-65" morph="none" pos="unknown" start_char="2625">COVID-19</TOKEN>
<TOKEN end_char="2638" id="token-8-66" morph="none" pos="word" start_char="2634">fuera</TOKEN>
<TOKEN end_char="2642" id="token-8-67" morph="none" pos="word" start_char="2640">del</TOKEN>
<TOKEN end_char="2651" id="token-8-68" morph="none" pos="word" start_char="2644">hospital</TOKEN>
<TOKEN end_char="2653" id="token-8-69" morph="none" pos="punct" start_char="2652">",</TOKEN>
<TOKEN end_char="2658" id="token-8-70" morph="none" pos="word" start_char="2655">dijo</TOKEN>
<TOKEN end_char="2661" id="token-8-71" morph="none" pos="word" start_char="2660">la</TOKEN>
<TOKEN end_char="2669" id="token-8-72" morph="none" pos="word" start_char="2663">doctora</TOKEN>
<TOKEN end_char="2678" id="token-8-73" morph="none" pos="word" start_char="2671">Patrizia</TOKEN>
<TOKEN end_char="2688" id="token-8-74" morph="none" pos="word" start_char="2680">Cavazzoni</TOKEN>
<TOKEN end_char="2689" id="token-8-75" morph="none" pos="punct" start_char="2689">,</TOKEN>
<TOKEN end_char="2693" id="token-8-76" morph="none" pos="unknown" start_char="2691">M.D</TOKEN>
<TOKEN end_char="2695" id="token-8-77" morph="none" pos="punct" start_char="2694">.,</TOKEN>
<TOKEN end_char="2705" id="token-8-78" morph="none" pos="word" start_char="2697">directora</TOKEN>
<TOKEN end_char="2709" id="token-8-79" morph="none" pos="word" start_char="2707">del</TOKEN>
<TOKEN end_char="2716" id="token-8-80" morph="none" pos="word" start_char="2711">Centro</TOKEN>
<TOKEN end_char="2719" id="token-8-81" morph="none" pos="word" start_char="2718">de</TOKEN>
<TOKEN end_char="2730" id="token-8-82" morph="none" pos="word" start_char="2721">Evaluación</TOKEN>
<TOKEN end_char="2732" id="token-8-83" morph="none" pos="word" start_char="2732">e</TOKEN>
<TOKEN end_char="2746" id="token-8-84" morph="none" pos="word" start_char="2734">Investigación</TOKEN>
<TOKEN end_char="2749" id="token-8-85" morph="none" pos="word" start_char="2748">de</TOKEN>
<TOKEN end_char="2762" id="token-8-86" morph="none" pos="word" start_char="2751">Medicamentos</TOKEN>
<TOKEN end_char="2765" id="token-8-87" morph="none" pos="word" start_char="2764">de</TOKEN>
<TOKEN end_char="2768" id="token-8-88" morph="none" pos="word" start_char="2767">la</TOKEN>
<TOKEN end_char="2772" id="token-8-89" morph="none" pos="word" start_char="2770">FDA</TOKEN>
<TOKEN end_char="2773" id="token-8-90" morph="none" pos="punct" start_char="2773">.</TOKEN>
<TRANSLATED_TEXT>"While the risk-benefit assessment for the use of bamlanivimab is only no longer favourable due to the increased frequency of resistant variants, other monoclonal antibody therapies authorized for emergency use remain appropriate treatment options when used according to the authorised indications and can help keep high-risk patients with COVID-19 out of the hospital," said Dr. Patrizia Cavazzoni, M.D., Director of the FDA's Drug Evaluation and Research Center.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3006" id="segment-9" start_char="2775">
<ORIGINAL_TEXT>"Instamos al público estadounidense a que busque estas terapias cuando las necesite mientras seguimos utilizando los mejores datos disponibles para proporcionar a los pacientes tratamientos seguros y eficaces durante esta pandemia".</ORIGINAL_TEXT>
<TOKEN end_char="2775" id="token-9-0" morph="none" pos="punct" start_char="2775">"</TOKEN>
<TOKEN end_char="2783" id="token-9-1" morph="none" pos="word" start_char="2776">Instamos</TOKEN>
<TOKEN end_char="2786" id="token-9-2" morph="none" pos="word" start_char="2785">al</TOKEN>
<TOKEN end_char="2794" id="token-9-3" morph="none" pos="word" start_char="2788">público</TOKEN>
<TOKEN end_char="2809" id="token-9-4" morph="none" pos="word" start_char="2796">estadounidense</TOKEN>
<TOKEN end_char="2811" id="token-9-5" morph="none" pos="word" start_char="2811">a</TOKEN>
<TOKEN end_char="2815" id="token-9-6" morph="none" pos="word" start_char="2813">que</TOKEN>
<TOKEN end_char="2822" id="token-9-7" morph="none" pos="word" start_char="2817">busque</TOKEN>
<TOKEN end_char="2828" id="token-9-8" morph="none" pos="word" start_char="2824">estas</TOKEN>
<TOKEN end_char="2837" id="token-9-9" morph="none" pos="word" start_char="2830">terapias</TOKEN>
<TOKEN end_char="2844" id="token-9-10" morph="none" pos="word" start_char="2839">cuando</TOKEN>
<TOKEN end_char="2848" id="token-9-11" morph="none" pos="word" start_char="2846">las</TOKEN>
<TOKEN end_char="2857" id="token-9-12" morph="none" pos="word" start_char="2850">necesite</TOKEN>
<TOKEN end_char="2866" id="token-9-13" morph="none" pos="word" start_char="2859">mientras</TOKEN>
<TOKEN end_char="2875" id="token-9-14" morph="none" pos="word" start_char="2868">seguimos</TOKEN>
<TOKEN end_char="2886" id="token-9-15" morph="none" pos="word" start_char="2877">utilizando</TOKEN>
<TOKEN end_char="2890" id="token-9-16" morph="none" pos="word" start_char="2888">los</TOKEN>
<TOKEN end_char="2898" id="token-9-17" morph="none" pos="word" start_char="2892">mejores</TOKEN>
<TOKEN end_char="2904" id="token-9-18" morph="none" pos="word" start_char="2900">datos</TOKEN>
<TOKEN end_char="2916" id="token-9-19" morph="none" pos="word" start_char="2906">disponibles</TOKEN>
<TOKEN end_char="2921" id="token-9-20" morph="none" pos="word" start_char="2918">para</TOKEN>
<TOKEN end_char="2934" id="token-9-21" morph="none" pos="word" start_char="2923">proporcionar</TOKEN>
<TOKEN end_char="2936" id="token-9-22" morph="none" pos="word" start_char="2936">a</TOKEN>
<TOKEN end_char="2940" id="token-9-23" morph="none" pos="word" start_char="2938">los</TOKEN>
<TOKEN end_char="2950" id="token-9-24" morph="none" pos="word" start_char="2942">pacientes</TOKEN>
<TOKEN end_char="2963" id="token-9-25" morph="none" pos="word" start_char="2952">tratamientos</TOKEN>
<TOKEN end_char="2971" id="token-9-26" morph="none" pos="word" start_char="2965">seguros</TOKEN>
<TOKEN end_char="2973" id="token-9-27" morph="none" pos="word" start_char="2973">y</TOKEN>
<TOKEN end_char="2982" id="token-9-28" morph="none" pos="word" start_char="2975">eficaces</TOKEN>
<TOKEN end_char="2990" id="token-9-29" morph="none" pos="word" start_char="2984">durante</TOKEN>
<TOKEN end_char="2995" id="token-9-30" morph="none" pos="word" start_char="2992">esta</TOKEN>
<TOKEN end_char="3004" id="token-9-31" morph="none" pos="word" start_char="2997">pandemia</TOKEN>
<TOKEN end_char="3006" id="token-9-32" morph="none" pos="punct" start_char="3005">".</TOKEN>
<TRANSLATED_TEXT>We urge the American public to seek these therapies when they are needed while continuing to use the best available data to provide patients with safe and effective treatments during this pandemic.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3201" id="segment-10" start_char="3009">
<ORIGINAL_TEXT>Los anticuerpos monoclonales son proteínas fabricadas en el laboratorio que imitan la capacidad del sistema inmunológico para luchar contra patógenos dañinos como los virus, como el SARS-CoV-2.</ORIGINAL_TEXT>
<TOKEN end_char="3011" id="token-10-0" morph="none" pos="word" start_char="3009">Los</TOKEN>
<TOKEN end_char="3023" id="token-10-1" morph="none" pos="word" start_char="3013">anticuerpos</TOKEN>
<TOKEN end_char="3036" id="token-10-2" morph="none" pos="word" start_char="3025">monoclonales</TOKEN>
<TOKEN end_char="3040" id="token-10-3" morph="none" pos="word" start_char="3038">son</TOKEN>
<TOKEN end_char="3050" id="token-10-4" morph="none" pos="word" start_char="3042">proteínas</TOKEN>
<TOKEN end_char="3061" id="token-10-5" morph="none" pos="word" start_char="3052">fabricadas</TOKEN>
<TOKEN end_char="3064" id="token-10-6" morph="none" pos="word" start_char="3063">en</TOKEN>
<TOKEN end_char="3067" id="token-10-7" morph="none" pos="word" start_char="3066">el</TOKEN>
<TOKEN end_char="3079" id="token-10-8" morph="none" pos="word" start_char="3069">laboratorio</TOKEN>
<TOKEN end_char="3083" id="token-10-9" morph="none" pos="word" start_char="3081">que</TOKEN>
<TOKEN end_char="3090" id="token-10-10" morph="none" pos="word" start_char="3085">imitan</TOKEN>
<TOKEN end_char="3093" id="token-10-11" morph="none" pos="word" start_char="3092">la</TOKEN>
<TOKEN end_char="3103" id="token-10-12" morph="none" pos="word" start_char="3095">capacidad</TOKEN>
<TOKEN end_char="3107" id="token-10-13" morph="none" pos="word" start_char="3105">del</TOKEN>
<TOKEN end_char="3115" id="token-10-14" morph="none" pos="word" start_char="3109">sistema</TOKEN>
<TOKEN end_char="3128" id="token-10-15" morph="none" pos="word" start_char="3117">inmunológico</TOKEN>
<TOKEN end_char="3133" id="token-10-16" morph="none" pos="word" start_char="3130">para</TOKEN>
<TOKEN end_char="3140" id="token-10-17" morph="none" pos="word" start_char="3135">luchar</TOKEN>
<TOKEN end_char="3147" id="token-10-18" morph="none" pos="word" start_char="3142">contra</TOKEN>
<TOKEN end_char="3157" id="token-10-19" morph="none" pos="word" start_char="3149">patógenos</TOKEN>
<TOKEN end_char="3165" id="token-10-20" morph="none" pos="word" start_char="3159">dañinos</TOKEN>
<TOKEN end_char="3170" id="token-10-21" morph="none" pos="word" start_char="3167">como</TOKEN>
<TOKEN end_char="3174" id="token-10-22" morph="none" pos="word" start_char="3172">los</TOKEN>
<TOKEN end_char="3180" id="token-10-23" morph="none" pos="word" start_char="3176">virus</TOKEN>
<TOKEN end_char="3181" id="token-10-24" morph="none" pos="punct" start_char="3181">,</TOKEN>
<TOKEN end_char="3186" id="token-10-25" morph="none" pos="word" start_char="3183">como</TOKEN>
<TOKEN end_char="3189" id="token-10-26" morph="none" pos="word" start_char="3188">el</TOKEN>
<TOKEN end_char="3200" id="token-10-27" morph="none" pos="unknown" start_char="3191">SARS-CoV-2</TOKEN>
<TOKEN end_char="3201" id="token-10-28" morph="none" pos="punct" start_char="3201">.</TOKEN>
<TRANSLATED_TEXT>Monoclonal antibodies are laboratory-made proteins that mimic the ability of the immune system to fight harmful pathogens such as viruses, such as SARS-CoV-2.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3377" id="segment-11" start_char="3203">
<ORIGINAL_TEXT>Al igual que otros organismos infecciosos, el SARS-CoV-2 puede mutar con el tiempo, lo que da lugar a una variación genética en la población de cepas del virus en circulación.</ORIGINAL_TEXT>
<TOKEN end_char="3204" id="token-11-0" morph="none" pos="word" start_char="3203">Al</TOKEN>
<TOKEN end_char="3210" id="token-11-1" morph="none" pos="word" start_char="3206">igual</TOKEN>
<TOKEN end_char="3214" id="token-11-2" morph="none" pos="word" start_char="3212">que</TOKEN>
<TOKEN end_char="3220" id="token-11-3" morph="none" pos="word" start_char="3216">otros</TOKEN>
<TOKEN end_char="3231" id="token-11-4" morph="none" pos="word" start_char="3222">organismos</TOKEN>
<TOKEN end_char="3243" id="token-11-5" morph="none" pos="word" start_char="3233">infecciosos</TOKEN>
<TOKEN end_char="3244" id="token-11-6" morph="none" pos="punct" start_char="3244">,</TOKEN>
<TOKEN end_char="3247" id="token-11-7" morph="none" pos="word" start_char="3246">el</TOKEN>
<TOKEN end_char="3258" id="token-11-8" morph="none" pos="unknown" start_char="3249">SARS-CoV-2</TOKEN>
<TOKEN end_char="3264" id="token-11-9" morph="none" pos="word" start_char="3260">puede</TOKEN>
<TOKEN end_char="3270" id="token-11-10" morph="none" pos="word" start_char="3266">mutar</TOKEN>
<TOKEN end_char="3274" id="token-11-11" morph="none" pos="word" start_char="3272">con</TOKEN>
<TOKEN end_char="3277" id="token-11-12" morph="none" pos="word" start_char="3276">el</TOKEN>
<TOKEN end_char="3284" id="token-11-13" morph="none" pos="word" start_char="3279">tiempo</TOKEN>
<TOKEN end_char="3285" id="token-11-14" morph="none" pos="punct" start_char="3285">,</TOKEN>
<TOKEN end_char="3288" id="token-11-15" morph="none" pos="word" start_char="3287">lo</TOKEN>
<TOKEN end_char="3292" id="token-11-16" morph="none" pos="word" start_char="3290">que</TOKEN>
<TOKEN end_char="3295" id="token-11-17" morph="none" pos="word" start_char="3294">da</TOKEN>
<TOKEN end_char="3301" id="token-11-18" morph="none" pos="word" start_char="3297">lugar</TOKEN>
<TOKEN end_char="3303" id="token-11-19" morph="none" pos="word" start_char="3303">a</TOKEN>
<TOKEN end_char="3307" id="token-11-20" morph="none" pos="word" start_char="3305">una</TOKEN>
<TOKEN end_char="3317" id="token-11-21" morph="none" pos="word" start_char="3309">variación</TOKEN>
<TOKEN end_char="3326" id="token-11-22" morph="none" pos="word" start_char="3319">genética</TOKEN>
<TOKEN end_char="3329" id="token-11-23" morph="none" pos="word" start_char="3328">en</TOKEN>
<TOKEN end_char="3332" id="token-11-24" morph="none" pos="word" start_char="3331">la</TOKEN>
<TOKEN end_char="3342" id="token-11-25" morph="none" pos="word" start_char="3334">población</TOKEN>
<TOKEN end_char="3345" id="token-11-26" morph="none" pos="word" start_char="3344">de</TOKEN>
<TOKEN end_char="3351" id="token-11-27" morph="none" pos="word" start_char="3347">cepas</TOKEN>
<TOKEN end_char="3355" id="token-11-28" morph="none" pos="word" start_char="3353">del</TOKEN>
<TOKEN end_char="3361" id="token-11-29" morph="none" pos="word" start_char="3357">virus</TOKEN>
<TOKEN end_char="3364" id="token-11-30" morph="none" pos="word" start_char="3363">en</TOKEN>
<TOKEN end_char="3376" id="token-11-31" morph="none" pos="word" start_char="3366">circulación</TOKEN>
<TOKEN end_char="3377" id="token-11-32" morph="none" pos="punct" start_char="3377">.</TOKEN>
<TRANSLATED_TEXT>Like other infectious organisms, SARS-CoV-2 can mutate over time, resulting in genetic variation in the population of circulating strains of the virus.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3580" id="segment-12" start_char="3380">
<ORIGINAL_TEXT>La FDA tiene la responsabilidad de revisar regularmente la idoneidad de una EUA, y como tal, la agencia revisará la información emergente asociada a los usos de emergencia de los productos autorizados.</ORIGINAL_TEXT>
<TOKEN end_char="3381" id="token-12-0" morph="none" pos="word" start_char="3380">La</TOKEN>
<TOKEN end_char="3385" id="token-12-1" morph="none" pos="word" start_char="3383">FDA</TOKEN>
<TOKEN end_char="3391" id="token-12-2" morph="none" pos="word" start_char="3387">tiene</TOKEN>
<TOKEN end_char="3394" id="token-12-3" morph="none" pos="word" start_char="3393">la</TOKEN>
<TOKEN end_char="3410" id="token-12-4" morph="none" pos="word" start_char="3396">responsabilidad</TOKEN>
<TOKEN end_char="3413" id="token-12-5" morph="none" pos="word" start_char="3412">de</TOKEN>
<TOKEN end_char="3421" id="token-12-6" morph="none" pos="word" start_char="3415">revisar</TOKEN>
<TOKEN end_char="3434" id="token-12-7" morph="none" pos="word" start_char="3423">regularmente</TOKEN>
<TOKEN end_char="3437" id="token-12-8" morph="none" pos="word" start_char="3436">la</TOKEN>
<TOKEN end_char="3447" id="token-12-9" morph="none" pos="word" start_char="3439">idoneidad</TOKEN>
<TOKEN end_char="3450" id="token-12-10" morph="none" pos="word" start_char="3449">de</TOKEN>
<TOKEN end_char="3454" id="token-12-11" morph="none" pos="word" start_char="3452">una</TOKEN>
<TOKEN end_char="3458" id="token-12-12" morph="none" pos="word" start_char="3456">EUA</TOKEN>
<TOKEN end_char="3459" id="token-12-13" morph="none" pos="punct" start_char="3459">,</TOKEN>
<TOKEN end_char="3461" id="token-12-14" morph="none" pos="word" start_char="3461">y</TOKEN>
<TOKEN end_char="3466" id="token-12-15" morph="none" pos="word" start_char="3463">como</TOKEN>
<TOKEN end_char="3470" id="token-12-16" morph="none" pos="word" start_char="3468">tal</TOKEN>
<TOKEN end_char="3471" id="token-12-17" morph="none" pos="punct" start_char="3471">,</TOKEN>
<TOKEN end_char="3474" id="token-12-18" morph="none" pos="word" start_char="3473">la</TOKEN>
<TOKEN end_char="3482" id="token-12-19" morph="none" pos="word" start_char="3476">agencia</TOKEN>
<TOKEN end_char="3491" id="token-12-20" morph="none" pos="word" start_char="3484">revisará</TOKEN>
<TOKEN end_char="3494" id="token-12-21" morph="none" pos="word" start_char="3493">la</TOKEN>
<TOKEN end_char="3506" id="token-12-22" morph="none" pos="word" start_char="3496">información</TOKEN>
<TOKEN end_char="3516" id="token-12-23" morph="none" pos="word" start_char="3508">emergente</TOKEN>
<TOKEN end_char="3525" id="token-12-24" morph="none" pos="word" start_char="3518">asociada</TOKEN>
<TOKEN end_char="3527" id="token-12-25" morph="none" pos="word" start_char="3527">a</TOKEN>
<TOKEN end_char="3531" id="token-12-26" morph="none" pos="word" start_char="3529">los</TOKEN>
<TOKEN end_char="3536" id="token-12-27" morph="none" pos="word" start_char="3533">usos</TOKEN>
<TOKEN end_char="3539" id="token-12-28" morph="none" pos="word" start_char="3538">de</TOKEN>
<TOKEN end_char="3550" id="token-12-29" morph="none" pos="word" start_char="3541">emergencia</TOKEN>
<TOKEN end_char="3553" id="token-12-30" morph="none" pos="word" start_char="3552">de</TOKEN>
<TOKEN end_char="3557" id="token-12-31" morph="none" pos="word" start_char="3555">los</TOKEN>
<TOKEN end_char="3567" id="token-12-32" morph="none" pos="word" start_char="3559">productos</TOKEN>
<TOKEN end_char="3579" id="token-12-33" morph="none" pos="word" start_char="3569">autorizados</TOKEN>
<TOKEN end_char="3580" id="token-12-34" morph="none" pos="punct" start_char="3580">.</TOKEN>
<TRANSLATED_TEXT>The FDA has the responsibility to regularly review the suitability of a U.S., and as such, the agency will review emerging information associated with the emergency uses of authorized products.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3751" id="segment-13" start_char="3582">
<ORIGINAL_TEXT>Los datos recientes del programa nacional de vigilancia genómica de los Centros para el Control y la Prevención de Enfermedades (CDC, por sus siglas en inglés) de los EE.</ORIGINAL_TEXT>
<TOKEN end_char="3584" id="token-13-0" morph="none" pos="word" start_char="3582">Los</TOKEN>
<TOKEN end_char="3590" id="token-13-1" morph="none" pos="word" start_char="3586">datos</TOKEN>
<TOKEN end_char="3600" id="token-13-2" morph="none" pos="word" start_char="3592">recientes</TOKEN>
<TOKEN end_char="3604" id="token-13-3" morph="none" pos="word" start_char="3602">del</TOKEN>
<TOKEN end_char="3613" id="token-13-4" morph="none" pos="word" start_char="3606">programa</TOKEN>
<TOKEN end_char="3622" id="token-13-5" morph="none" pos="word" start_char="3615">nacional</TOKEN>
<TOKEN end_char="3625" id="token-13-6" morph="none" pos="word" start_char="3624">de</TOKEN>
<TOKEN end_char="3636" id="token-13-7" morph="none" pos="word" start_char="3627">vigilancia</TOKEN>
<TOKEN end_char="3645" id="token-13-8" morph="none" pos="word" start_char="3638">genómica</TOKEN>
<TOKEN end_char="3648" id="token-13-9" morph="none" pos="word" start_char="3647">de</TOKEN>
<TOKEN end_char="3652" id="token-13-10" morph="none" pos="word" start_char="3650">los</TOKEN>
<TOKEN end_char="3660" id="token-13-11" morph="none" pos="word" start_char="3654">Centros</TOKEN>
<TOKEN end_char="3665" id="token-13-12" morph="none" pos="word" start_char="3662">para</TOKEN>
<TOKEN end_char="3668" id="token-13-13" morph="none" pos="word" start_char="3667">el</TOKEN>
<TOKEN end_char="3676" id="token-13-14" morph="none" pos="word" start_char="3670">Control</TOKEN>
<TOKEN end_char="3678" id="token-13-15" morph="none" pos="word" start_char="3678">y</TOKEN>
<TOKEN end_char="3681" id="token-13-16" morph="none" pos="word" start_char="3680">la</TOKEN>
<TOKEN end_char="3692" id="token-13-17" morph="none" pos="word" start_char="3683">Prevención</TOKEN>
<TOKEN end_char="3695" id="token-13-18" morph="none" pos="word" start_char="3694">de</TOKEN>
<TOKEN end_char="3708" id="token-13-19" morph="none" pos="word" start_char="3697">Enfermedades</TOKEN>
<TOKEN end_char="3710" id="token-13-20" morph="none" pos="punct" start_char="3710">(</TOKEN>
<TOKEN end_char="3713" id="token-13-21" morph="none" pos="word" start_char="3711">CDC</TOKEN>
<TOKEN end_char="3714" id="token-13-22" morph="none" pos="punct" start_char="3714">,</TOKEN>
<TOKEN end_char="3718" id="token-13-23" morph="none" pos="word" start_char="3716">por</TOKEN>
<TOKEN end_char="3722" id="token-13-24" morph="none" pos="word" start_char="3720">sus</TOKEN>
<TOKEN end_char="3729" id="token-13-25" morph="none" pos="word" start_char="3724">siglas</TOKEN>
<TOKEN end_char="3732" id="token-13-26" morph="none" pos="word" start_char="3731">en</TOKEN>
<TOKEN end_char="3739" id="token-13-27" morph="none" pos="word" start_char="3734">inglés</TOKEN>
<TOKEN end_char="3740" id="token-13-28" morph="none" pos="punct" start_char="3740">)</TOKEN>
<TOKEN end_char="3743" id="token-13-29" morph="none" pos="word" start_char="3742">de</TOKEN>
<TOKEN end_char="3747" id="token-13-30" morph="none" pos="word" start_char="3745">los</TOKEN>
<TOKEN end_char="3750" id="token-13-31" morph="none" pos="word" start_char="3749">EE</TOKEN>
<TOKEN end_char="3751" id="token-13-32" morph="none" pos="punct" start_char="3751">.</TOKEN>
<TRANSLATED_TEXT>Recent data from the U.S. Centers for Disease Control and Prevention (CDC) National Genomic Surveillance Program.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3755" id="segment-14" start_char="3753">
<ORIGINAL_TEXT>UU.</ORIGINAL_TEXT>
<TOKEN end_char="3754" id="token-14-0" morph="none" pos="word" start_char="3753">UU</TOKEN>
<TOKEN end_char="3755" id="token-14-1" morph="none" pos="punct" start_char="3755">.</TOKEN>
<TRANSLATED_TEXT>U.</TRANSLATED_TEXT><DETECTED_LANGUAGE>sw</DETECTED_LANGUAGE></SEG>
<SEG end_char="3883" id="segment-15" start_char="3757">
<ORIGINAL_TEXT>muestran una mayor frecuencia de variantes del SARS-CoV-2 que se espera que sean resistentes al bamlanivimab administrado solo.</ORIGINAL_TEXT>
<TOKEN end_char="3764" id="token-15-0" morph="none" pos="word" start_char="3757">muestran</TOKEN>
<TOKEN end_char="3768" id="token-15-1" morph="none" pos="word" start_char="3766">una</TOKEN>
<TOKEN end_char="3774" id="token-15-2" morph="none" pos="word" start_char="3770">mayor</TOKEN>
<TOKEN end_char="3785" id="token-15-3" morph="none" pos="word" start_char="3776">frecuencia</TOKEN>
<TOKEN end_char="3788" id="token-15-4" morph="none" pos="word" start_char="3787">de</TOKEN>
<TOKEN end_char="3798" id="token-15-5" morph="none" pos="word" start_char="3790">variantes</TOKEN>
<TOKEN end_char="3802" id="token-15-6" morph="none" pos="word" start_char="3800">del</TOKEN>
<TOKEN end_char="3813" id="token-15-7" morph="none" pos="unknown" start_char="3804">SARS-CoV-2</TOKEN>
<TOKEN end_char="3817" id="token-15-8" morph="none" pos="word" start_char="3815">que</TOKEN>
<TOKEN end_char="3820" id="token-15-9" morph="none" pos="word" start_char="3819">se</TOKEN>
<TOKEN end_char="3827" id="token-15-10" morph="none" pos="word" start_char="3822">espera</TOKEN>
<TOKEN end_char="3831" id="token-15-11" morph="none" pos="word" start_char="3829">que</TOKEN>
<TOKEN end_char="3836" id="token-15-12" morph="none" pos="word" start_char="3833">sean</TOKEN>
<TOKEN end_char="3848" id="token-15-13" morph="none" pos="word" start_char="3838">resistentes</TOKEN>
<TOKEN end_char="3851" id="token-15-14" morph="none" pos="word" start_char="3850">al</TOKEN>
<TOKEN end_char="3864" id="token-15-15" morph="none" pos="word" start_char="3853">bamlanivimab</TOKEN>
<TOKEN end_char="3877" id="token-15-16" morph="none" pos="word" start_char="3866">administrado</TOKEN>
<TOKEN end_char="3882" id="token-15-17" morph="none" pos="word" start_char="3879">solo</TOKEN>
<TOKEN end_char="3883" id="token-15-18" morph="none" pos="punct" start_char="3883">.</TOKEN>
<TRANSLATED_TEXT>They show a higher frequency of SARS-CoV-2 variants that are expected to be resistant to only administered bamlanivimab.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="4132" id="segment-16" start_char="3885">
<ORIGINAL_TEXT>A mediados de marzo de 2021, aproximadamente el 20% de los virus secuenciados en los EE.UU. fueron reportados como variantes que se espera que sean resistentes a bamlanivimab solo, aumentando desde aproximadamente el 5% a mediados de enero de 2021.</ORIGINAL_TEXT>
<TOKEN end_char="3885" id="token-16-0" morph="none" pos="word" start_char="3885">A</TOKEN>
<TOKEN end_char="3894" id="token-16-1" morph="none" pos="word" start_char="3887">mediados</TOKEN>
<TOKEN end_char="3897" id="token-16-2" morph="none" pos="word" start_char="3896">de</TOKEN>
<TOKEN end_char="3903" id="token-16-3" morph="none" pos="word" start_char="3899">marzo</TOKEN>
<TOKEN end_char="3906" id="token-16-4" morph="none" pos="word" start_char="3905">de</TOKEN>
<TOKEN end_char="3911" id="token-16-5" morph="none" pos="word" start_char="3908">2021</TOKEN>
<TOKEN end_char="3912" id="token-16-6" morph="none" pos="punct" start_char="3912">,</TOKEN>
<TOKEN end_char="3928" id="token-16-7" morph="none" pos="word" start_char="3914">aproximadamente</TOKEN>
<TOKEN end_char="3931" id="token-16-8" morph="none" pos="word" start_char="3930">el</TOKEN>
<TOKEN end_char="3934" id="token-16-9" morph="none" pos="word" start_char="3933">20</TOKEN>
<TOKEN end_char="3935" id="token-16-10" morph="none" pos="punct" start_char="3935">%</TOKEN>
<TOKEN end_char="3938" id="token-16-11" morph="none" pos="word" start_char="3937">de</TOKEN>
<TOKEN end_char="3942" id="token-16-12" morph="none" pos="word" start_char="3940">los</TOKEN>
<TOKEN end_char="3948" id="token-16-13" morph="none" pos="word" start_char="3944">virus</TOKEN>
<TOKEN end_char="3961" id="token-16-14" morph="none" pos="word" start_char="3950">secuenciados</TOKEN>
<TOKEN end_char="3964" id="token-16-15" morph="none" pos="word" start_char="3963">en</TOKEN>
<TOKEN end_char="3968" id="token-16-16" morph="none" pos="word" start_char="3966">los</TOKEN>
<TOKEN end_char="3974" id="token-16-17" morph="none" pos="unknown" start_char="3970">EE.UU</TOKEN>
<TOKEN end_char="3975" id="token-16-18" morph="none" pos="punct" start_char="3975">.</TOKEN>
<TOKEN end_char="3982" id="token-16-19" morph="none" pos="word" start_char="3977">fueron</TOKEN>
<TOKEN end_char="3993" id="token-16-20" morph="none" pos="word" start_char="3984">reportados</TOKEN>
<TOKEN end_char="3998" id="token-16-21" morph="none" pos="word" start_char="3995">como</TOKEN>
<TOKEN end_char="4008" id="token-16-22" morph="none" pos="word" start_char="4000">variantes</TOKEN>
<TOKEN end_char="4012" id="token-16-23" morph="none" pos="word" start_char="4010">que</TOKEN>
<TOKEN end_char="4015" id="token-16-24" morph="none" pos="word" start_char="4014">se</TOKEN>
<TOKEN end_char="4022" id="token-16-25" morph="none" pos="word" start_char="4017">espera</TOKEN>
<TOKEN end_char="4026" id="token-16-26" morph="none" pos="word" start_char="4024">que</TOKEN>
<TOKEN end_char="4031" id="token-16-27" morph="none" pos="word" start_char="4028">sean</TOKEN>
<TOKEN end_char="4043" id="token-16-28" morph="none" pos="word" start_char="4033">resistentes</TOKEN>
<TOKEN end_char="4045" id="token-16-29" morph="none" pos="word" start_char="4045">a</TOKEN>
<TOKEN end_char="4058" id="token-16-30" morph="none" pos="word" start_char="4047">bamlanivimab</TOKEN>
<TOKEN end_char="4063" id="token-16-31" morph="none" pos="word" start_char="4060">solo</TOKEN>
<TOKEN end_char="4064" id="token-16-32" morph="none" pos="punct" start_char="4064">,</TOKEN>
<TOKEN end_char="4075" id="token-16-33" morph="none" pos="word" start_char="4066">aumentando</TOKEN>
<TOKEN end_char="4081" id="token-16-34" morph="none" pos="word" start_char="4077">desde</TOKEN>
<TOKEN end_char="4097" id="token-16-35" morph="none" pos="word" start_char="4083">aproximadamente</TOKEN>
<TOKEN end_char="4100" id="token-16-36" morph="none" pos="word" start_char="4099">el</TOKEN>
<TOKEN end_char="4102" id="token-16-37" morph="none" pos="word" start_char="4102">5</TOKEN>
<TOKEN end_char="4103" id="token-16-38" morph="none" pos="punct" start_char="4103">%</TOKEN>
<TOKEN end_char="4105" id="token-16-39" morph="none" pos="word" start_char="4105">a</TOKEN>
<TOKEN end_char="4114" id="token-16-40" morph="none" pos="word" start_char="4107">mediados</TOKEN>
<TOKEN end_char="4117" id="token-16-41" morph="none" pos="word" start_char="4116">de</TOKEN>
<TOKEN end_char="4123" id="token-16-42" morph="none" pos="word" start_char="4119">enero</TOKEN>
<TOKEN end_char="4126" id="token-16-43" morph="none" pos="word" start_char="4125">de</TOKEN>
<TOKEN end_char="4131" id="token-16-44" morph="none" pos="word" start_char="4128">2021</TOKEN>
<TOKEN end_char="4132" id="token-16-45" morph="none" pos="punct" start_char="4132">.</TOKEN>
<TRANSLATED_TEXT>By mid-March 2021, approximately 20% of sequenced viruses in the US were reported as variants expected to be resistant to bamlanivimab alone, increasing from approximately 5% by mid-January 2021.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="4387" id="segment-17" start_char="4135">
<ORIGINAL_TEXT>Además, actualmente no hay tecnologías de prueba disponibles que permitan a los proveedores de atención médica analizar a los pacientes individuales para las variantes virales del SARS-CoV-2 antes de comenzar el tratamiento con anticuerpos monoclonales.</ORIGINAL_TEXT>
<TOKEN end_char="4140" id="token-17-0" morph="none" pos="word" start_char="4135">Además</TOKEN>
<TOKEN end_char="4141" id="token-17-1" morph="none" pos="punct" start_char="4141">,</TOKEN>
<TOKEN end_char="4153" id="token-17-2" morph="none" pos="word" start_char="4143">actualmente</TOKEN>
<TOKEN end_char="4156" id="token-17-3" morph="none" pos="word" start_char="4155">no</TOKEN>
<TOKEN end_char="4160" id="token-17-4" morph="none" pos="word" start_char="4158">hay</TOKEN>
<TOKEN end_char="4172" id="token-17-5" morph="none" pos="word" start_char="4162">tecnologías</TOKEN>
<TOKEN end_char="4175" id="token-17-6" morph="none" pos="word" start_char="4174">de</TOKEN>
<TOKEN end_char="4182" id="token-17-7" morph="none" pos="word" start_char="4177">prueba</TOKEN>
<TOKEN end_char="4194" id="token-17-8" morph="none" pos="word" start_char="4184">disponibles</TOKEN>
<TOKEN end_char="4198" id="token-17-9" morph="none" pos="word" start_char="4196">que</TOKEN>
<TOKEN end_char="4207" id="token-17-10" morph="none" pos="word" start_char="4200">permitan</TOKEN>
<TOKEN end_char="4209" id="token-17-11" morph="none" pos="word" start_char="4209">a</TOKEN>
<TOKEN end_char="4213" id="token-17-12" morph="none" pos="word" start_char="4211">los</TOKEN>
<TOKEN end_char="4225" id="token-17-13" morph="none" pos="word" start_char="4215">proveedores</TOKEN>
<TOKEN end_char="4228" id="token-17-14" morph="none" pos="word" start_char="4227">de</TOKEN>
<TOKEN end_char="4237" id="token-17-15" morph="none" pos="word" start_char="4230">atención</TOKEN>
<TOKEN end_char="4244" id="token-17-16" morph="none" pos="word" start_char="4239">médica</TOKEN>
<TOKEN end_char="4253" id="token-17-17" morph="none" pos="word" start_char="4246">analizar</TOKEN>
<TOKEN end_char="4255" id="token-17-18" morph="none" pos="word" start_char="4255">a</TOKEN>
<TOKEN end_char="4259" id="token-17-19" morph="none" pos="word" start_char="4257">los</TOKEN>
<TOKEN end_char="4269" id="token-17-20" morph="none" pos="word" start_char="4261">pacientes</TOKEN>
<TOKEN end_char="4282" id="token-17-21" morph="none" pos="word" start_char="4271">individuales</TOKEN>
<TOKEN end_char="4287" id="token-17-22" morph="none" pos="word" start_char="4284">para</TOKEN>
<TOKEN end_char="4291" id="token-17-23" morph="none" pos="word" start_char="4289">las</TOKEN>
<TOKEN end_char="4301" id="token-17-24" morph="none" pos="word" start_char="4293">variantes</TOKEN>
<TOKEN end_char="4309" id="token-17-25" morph="none" pos="word" start_char="4303">virales</TOKEN>
<TOKEN end_char="4313" id="token-17-26" morph="none" pos="word" start_char="4311">del</TOKEN>
<TOKEN end_char="4324" id="token-17-27" morph="none" pos="unknown" start_char="4315">SARS-CoV-2</TOKEN>
<TOKEN end_char="4330" id="token-17-28" morph="none" pos="word" start_char="4326">antes</TOKEN>
<TOKEN end_char="4333" id="token-17-29" morph="none" pos="word" start_char="4332">de</TOKEN>
<TOKEN end_char="4342" id="token-17-30" morph="none" pos="word" start_char="4335">comenzar</TOKEN>
<TOKEN end_char="4345" id="token-17-31" morph="none" pos="word" start_char="4344">el</TOKEN>
<TOKEN end_char="4357" id="token-17-32" morph="none" pos="word" start_char="4347">tratamiento</TOKEN>
<TOKEN end_char="4361" id="token-17-33" morph="none" pos="word" start_char="4359">con</TOKEN>
<TOKEN end_char="4373" id="token-17-34" morph="none" pos="word" start_char="4363">anticuerpos</TOKEN>
<TOKEN end_char="4386" id="token-17-35" morph="none" pos="word" start_char="4375">monoclonales</TOKEN>
<TOKEN end_char="4387" id="token-17-36" morph="none" pos="punct" start_char="4387">.</TOKEN>
<TRANSLATED_TEXT>In addition, there are currently no test technologies available to allow health care providers to analyze individual patients for the viral variants of SARS-CoV-2 before starting treatment with monoclonal antibodies.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="4622" id="segment-18" start_char="4389">
<ORIGINAL_TEXT>Por lo tanto, el tratamiento empírico con terapias de anticuerpos monoclonales que se espera que funcionen ampliamente contra todas las variantes en todo el país debe utilizarse para reducir la probabilidad de fracaso del tratamiento.</ORIGINAL_TEXT>
<TOKEN end_char="4391" id="token-18-0" morph="none" pos="word" start_char="4389">Por</TOKEN>
<TOKEN end_char="4394" id="token-18-1" morph="none" pos="word" start_char="4393">lo</TOKEN>
<TOKEN end_char="4400" id="token-18-2" morph="none" pos="word" start_char="4396">tanto</TOKEN>
<TOKEN end_char="4401" id="token-18-3" morph="none" pos="punct" start_char="4401">,</TOKEN>
<TOKEN end_char="4404" id="token-18-4" morph="none" pos="word" start_char="4403">el</TOKEN>
<TOKEN end_char="4416" id="token-18-5" morph="none" pos="word" start_char="4406">tratamiento</TOKEN>
<TOKEN end_char="4425" id="token-18-6" morph="none" pos="word" start_char="4418">empírico</TOKEN>
<TOKEN end_char="4429" id="token-18-7" morph="none" pos="word" start_char="4427">con</TOKEN>
<TOKEN end_char="4438" id="token-18-8" morph="none" pos="word" start_char="4431">terapias</TOKEN>
<TOKEN end_char="4441" id="token-18-9" morph="none" pos="word" start_char="4440">de</TOKEN>
<TOKEN end_char="4453" id="token-18-10" morph="none" pos="word" start_char="4443">anticuerpos</TOKEN>
<TOKEN end_char="4466" id="token-18-11" morph="none" pos="word" start_char="4455">monoclonales</TOKEN>
<TOKEN end_char="4470" id="token-18-12" morph="none" pos="word" start_char="4468">que</TOKEN>
<TOKEN end_char="4473" id="token-18-13" morph="none" pos="word" start_char="4472">se</TOKEN>
<TOKEN end_char="4480" id="token-18-14" morph="none" pos="word" start_char="4475">espera</TOKEN>
<TOKEN end_char="4484" id="token-18-15" morph="none" pos="word" start_char="4482">que</TOKEN>
<TOKEN end_char="4494" id="token-18-16" morph="none" pos="word" start_char="4486">funcionen</TOKEN>
<TOKEN end_char="4506" id="token-18-17" morph="none" pos="word" start_char="4496">ampliamente</TOKEN>
<TOKEN end_char="4513" id="token-18-18" morph="none" pos="word" start_char="4508">contra</TOKEN>
<TOKEN end_char="4519" id="token-18-19" morph="none" pos="word" start_char="4515">todas</TOKEN>
<TOKEN end_char="4523" id="token-18-20" morph="none" pos="word" start_char="4521">las</TOKEN>
<TOKEN end_char="4533" id="token-18-21" morph="none" pos="word" start_char="4525">variantes</TOKEN>
<TOKEN end_char="4536" id="token-18-22" morph="none" pos="word" start_char="4535">en</TOKEN>
<TOKEN end_char="4541" id="token-18-23" morph="none" pos="word" start_char="4538">todo</TOKEN>
<TOKEN end_char="4544" id="token-18-24" morph="none" pos="word" start_char="4543">el</TOKEN>
<TOKEN end_char="4549" id="token-18-25" morph="none" pos="word" start_char="4546">país</TOKEN>
<TOKEN end_char="4554" id="token-18-26" morph="none" pos="word" start_char="4551">debe</TOKEN>
<TOKEN end_char="4565" id="token-18-27" morph="none" pos="word" start_char="4556">utilizarse</TOKEN>
<TOKEN end_char="4570" id="token-18-28" morph="none" pos="word" start_char="4567">para</TOKEN>
<TOKEN end_char="4578" id="token-18-29" morph="none" pos="word" start_char="4572">reducir</TOKEN>
<TOKEN end_char="4581" id="token-18-30" morph="none" pos="word" start_char="4580">la</TOKEN>
<TOKEN end_char="4594" id="token-18-31" morph="none" pos="word" start_char="4583">probabilidad</TOKEN>
<TOKEN end_char="4597" id="token-18-32" morph="none" pos="word" start_char="4596">de</TOKEN>
<TOKEN end_char="4605" id="token-18-33" morph="none" pos="word" start_char="4599">fracaso</TOKEN>
<TOKEN end_char="4609" id="token-18-34" morph="none" pos="word" start_char="4607">del</TOKEN>
<TOKEN end_char="4621" id="token-18-35" morph="none" pos="word" start_char="4611">tratamiento</TOKEN>
<TOKEN end_char="4622" id="token-18-36" morph="none" pos="punct" start_char="4622">.</TOKEN>
<TRANSLATED_TEXT>Therefore, empirical treatment with monoclonal antibody therapies that are expected to work widely against all variants across the country should be used to reduce the likelihood of treatment failure.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="4898" id="segment-19" start_char="4625">
<ORIGINAL_TEXT>La FDA seguirá colaborando estrechamente con otras agencias gubernamentales federales, incluidos los CDC y los Institutos Nacionales de Salud, en la vigilancia de las variantes que puedan afectar a las terapias de anticuerpos monoclonales autorizadas para uso de emergencia.</ORIGINAL_TEXT>
<TOKEN end_char="4626" id="token-19-0" morph="none" pos="word" start_char="4625">La</TOKEN>
<TOKEN end_char="4630" id="token-19-1" morph="none" pos="word" start_char="4628">FDA</TOKEN>
<TOKEN end_char="4638" id="token-19-2" morph="none" pos="word" start_char="4632">seguirá</TOKEN>
<TOKEN end_char="4650" id="token-19-3" morph="none" pos="word" start_char="4640">colaborando</TOKEN>
<TOKEN end_char="4664" id="token-19-4" morph="none" pos="word" start_char="4652">estrechamente</TOKEN>
<TOKEN end_char="4668" id="token-19-5" morph="none" pos="word" start_char="4666">con</TOKEN>
<TOKEN end_char="4674" id="token-19-6" morph="none" pos="word" start_char="4670">otras</TOKEN>
<TOKEN end_char="4683" id="token-19-7" morph="none" pos="word" start_char="4676">agencias</TOKEN>
<TOKEN end_char="4699" id="token-19-8" morph="none" pos="word" start_char="4685">gubernamentales</TOKEN>
<TOKEN end_char="4709" id="token-19-9" morph="none" pos="word" start_char="4701">federales</TOKEN>
<TOKEN end_char="4710" id="token-19-10" morph="none" pos="punct" start_char="4710">,</TOKEN>
<TOKEN end_char="4720" id="token-19-11" morph="none" pos="word" start_char="4712">incluidos</TOKEN>
<TOKEN end_char="4724" id="token-19-12" morph="none" pos="word" start_char="4722">los</TOKEN>
<TOKEN end_char="4728" id="token-19-13" morph="none" pos="word" start_char="4726">CDC</TOKEN>
<TOKEN end_char="4730" id="token-19-14" morph="none" pos="word" start_char="4730">y</TOKEN>
<TOKEN end_char="4734" id="token-19-15" morph="none" pos="word" start_char="4732">los</TOKEN>
<TOKEN end_char="4745" id="token-19-16" morph="none" pos="word" start_char="4736">Institutos</TOKEN>
<TOKEN end_char="4756" id="token-19-17" morph="none" pos="word" start_char="4747">Nacionales</TOKEN>
<TOKEN end_char="4759" id="token-19-18" morph="none" pos="word" start_char="4758">de</TOKEN>
<TOKEN end_char="4765" id="token-19-19" morph="none" pos="word" start_char="4761">Salud</TOKEN>
<TOKEN end_char="4766" id="token-19-20" morph="none" pos="punct" start_char="4766">,</TOKEN>
<TOKEN end_char="4769" id="token-19-21" morph="none" pos="word" start_char="4768">en</TOKEN>
<TOKEN end_char="4772" id="token-19-22" morph="none" pos="word" start_char="4771">la</TOKEN>
<TOKEN end_char="4783" id="token-19-23" morph="none" pos="word" start_char="4774">vigilancia</TOKEN>
<TOKEN end_char="4786" id="token-19-24" morph="none" pos="word" start_char="4785">de</TOKEN>
<TOKEN end_char="4790" id="token-19-25" morph="none" pos="word" start_char="4788">las</TOKEN>
<TOKEN end_char="4800" id="token-19-26" morph="none" pos="word" start_char="4792">variantes</TOKEN>
<TOKEN end_char="4804" id="token-19-27" morph="none" pos="word" start_char="4802">que</TOKEN>
<TOKEN end_char="4811" id="token-19-28" morph="none" pos="word" start_char="4806">puedan</TOKEN>
<TOKEN end_char="4819" id="token-19-29" morph="none" pos="word" start_char="4813">afectar</TOKEN>
<TOKEN end_char="4821" id="token-19-30" morph="none" pos="word" start_char="4821">a</TOKEN>
<TOKEN end_char="4825" id="token-19-31" morph="none" pos="word" start_char="4823">las</TOKEN>
<TOKEN end_char="4834" id="token-19-32" morph="none" pos="word" start_char="4827">terapias</TOKEN>
<TOKEN end_char="4837" id="token-19-33" morph="none" pos="word" start_char="4836">de</TOKEN>
<TOKEN end_char="4849" id="token-19-34" morph="none" pos="word" start_char="4839">anticuerpos</TOKEN>
<TOKEN end_char="4862" id="token-19-35" morph="none" pos="word" start_char="4851">monoclonales</TOKEN>
<TOKEN end_char="4874" id="token-19-36" morph="none" pos="word" start_char="4864">autorizadas</TOKEN>
<TOKEN end_char="4879" id="token-19-37" morph="none" pos="word" start_char="4876">para</TOKEN>
<TOKEN end_char="4883" id="token-19-38" morph="none" pos="word" start_char="4881">uso</TOKEN>
<TOKEN end_char="4886" id="token-19-39" morph="none" pos="word" start_char="4885">de</TOKEN>
<TOKEN end_char="4897" id="token-19-40" morph="none" pos="word" start_char="4888">emergencia</TOKEN>
<TOKEN end_char="4898" id="token-19-41" morph="none" pos="punct" start_char="4898">.</TOKEN>
<TRANSLATED_TEXT>The FDA will continue to work closely with other federal government agencies, including the CDC and the National Institutes of Health, to monitor variants that may affect approved monoclonal antibody therapies for emergency use.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="5039" id="segment-20" start_char="4900">
<ORIGINAL_TEXT>La agencia sigue comprometida a proporcionar una comunicación oportuna y transparente a medida que la información adicional esté disponible.</ORIGINAL_TEXT>
<TOKEN end_char="4901" id="token-20-0" morph="none" pos="word" start_char="4900">La</TOKEN>
<TOKEN end_char="4909" id="token-20-1" morph="none" pos="word" start_char="4903">agencia</TOKEN>
<TOKEN end_char="4915" id="token-20-2" morph="none" pos="word" start_char="4911">sigue</TOKEN>
<TOKEN end_char="4928" id="token-20-3" morph="none" pos="word" start_char="4917">comprometida</TOKEN>
<TOKEN end_char="4930" id="token-20-4" morph="none" pos="word" start_char="4930">a</TOKEN>
<TOKEN end_char="4943" id="token-20-5" morph="none" pos="word" start_char="4932">proporcionar</TOKEN>
<TOKEN end_char="4947" id="token-20-6" morph="none" pos="word" start_char="4945">una</TOKEN>
<TOKEN end_char="4960" id="token-20-7" morph="none" pos="word" start_char="4949">comunicación</TOKEN>
<TOKEN end_char="4969" id="token-20-8" morph="none" pos="word" start_char="4962">oportuna</TOKEN>
<TOKEN end_char="4971" id="token-20-9" morph="none" pos="word" start_char="4971">y</TOKEN>
<TOKEN end_char="4984" id="token-20-10" morph="none" pos="word" start_char="4973">transparente</TOKEN>
<TOKEN end_char="4986" id="token-20-11" morph="none" pos="word" start_char="4986">a</TOKEN>
<TOKEN end_char="4993" id="token-20-12" morph="none" pos="word" start_char="4988">medida</TOKEN>
<TOKEN end_char="4997" id="token-20-13" morph="none" pos="word" start_char="4995">que</TOKEN>
<TOKEN end_char="5000" id="token-20-14" morph="none" pos="word" start_char="4999">la</TOKEN>
<TOKEN end_char="5012" id="token-20-15" morph="none" pos="word" start_char="5002">información</TOKEN>
<TOKEN end_char="5022" id="token-20-16" morph="none" pos="word" start_char="5014">adicional</TOKEN>
<TOKEN end_char="5027" id="token-20-17" morph="none" pos="word" start_char="5024">esté</TOKEN>
<TOKEN end_char="5038" id="token-20-18" morph="none" pos="word" start_char="5029">disponible</TOKEN>
<TOKEN end_char="5039" id="token-20-19" morph="none" pos="punct" start_char="5039">.</TOKEN>
<TRANSLATED_TEXT>The agency remains committed to providing timely and transparent communication as additional information becomes available.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="5389" id="segment-21" start_char="5042">
<ORIGINAL_TEXT>La FDA, una dependencia del Departamento de Salud y Servicios Sociales de los Estados Unidos, protege la salud pública asegurando la protección, eficacia y seguridad de los medicamentos tanto veterinarios como para los seres humanos, las vacunas y otros productos biológicos destinados al uso en seres humanos, así como de los dispositivos médicos.</ORIGINAL_TEXT>
<TOKEN end_char="5043" id="token-21-0" morph="none" pos="word" start_char="5042">La</TOKEN>
<TOKEN end_char="5047" id="token-21-1" morph="none" pos="word" start_char="5045">FDA</TOKEN>
<TOKEN end_char="5048" id="token-21-2" morph="none" pos="punct" start_char="5048">,</TOKEN>
<TOKEN end_char="5052" id="token-21-3" morph="none" pos="word" start_char="5050">una</TOKEN>
<TOKEN end_char="5064" id="token-21-4" morph="none" pos="word" start_char="5054">dependencia</TOKEN>
<TOKEN end_char="5068" id="token-21-5" morph="none" pos="word" start_char="5066">del</TOKEN>
<TOKEN end_char="5081" id="token-21-6" morph="none" pos="word" start_char="5070">Departamento</TOKEN>
<TOKEN end_char="5084" id="token-21-7" morph="none" pos="word" start_char="5083">de</TOKEN>
<TOKEN end_char="5090" id="token-21-8" morph="none" pos="word" start_char="5086">Salud</TOKEN>
<TOKEN end_char="5092" id="token-21-9" morph="none" pos="word" start_char="5092">y</TOKEN>
<TOKEN end_char="5102" id="token-21-10" morph="none" pos="word" start_char="5094">Servicios</TOKEN>
<TOKEN end_char="5111" id="token-21-11" morph="none" pos="word" start_char="5104">Sociales</TOKEN>
<TOKEN end_char="5114" id="token-21-12" morph="none" pos="word" start_char="5113">de</TOKEN>
<TOKEN end_char="5118" id="token-21-13" morph="none" pos="word" start_char="5116">los</TOKEN>
<TOKEN end_char="5126" id="token-21-14" morph="none" pos="word" start_char="5120">Estados</TOKEN>
<TOKEN end_char="5133" id="token-21-15" morph="none" pos="word" start_char="5128">Unidos</TOKEN>
<TOKEN end_char="5134" id="token-21-16" morph="none" pos="punct" start_char="5134">,</TOKEN>
<TOKEN end_char="5142" id="token-21-17" morph="none" pos="word" start_char="5136">protege</TOKEN>
<TOKEN end_char="5145" id="token-21-18" morph="none" pos="word" start_char="5144">la</TOKEN>
<TOKEN end_char="5151" id="token-21-19" morph="none" pos="word" start_char="5147">salud</TOKEN>
<TOKEN end_char="5159" id="token-21-20" morph="none" pos="word" start_char="5153">pública</TOKEN>
<TOKEN end_char="5170" id="token-21-21" morph="none" pos="word" start_char="5161">asegurando</TOKEN>
<TOKEN end_char="5173" id="token-21-22" morph="none" pos="word" start_char="5172">la</TOKEN>
<TOKEN end_char="5184" id="token-21-23" morph="none" pos="word" start_char="5175">protección</TOKEN>
<TOKEN end_char="5185" id="token-21-24" morph="none" pos="punct" start_char="5185">,</TOKEN>
<TOKEN end_char="5194" id="token-21-25" morph="none" pos="word" start_char="5187">eficacia</TOKEN>
<TOKEN end_char="5196" id="token-21-26" morph="none" pos="word" start_char="5196">y</TOKEN>
<TOKEN end_char="5206" id="token-21-27" morph="none" pos="word" start_char="5198">seguridad</TOKEN>
<TOKEN end_char="5209" id="token-21-28" morph="none" pos="word" start_char="5208">de</TOKEN>
<TOKEN end_char="5213" id="token-21-29" morph="none" pos="word" start_char="5211">los</TOKEN>
<TOKEN end_char="5226" id="token-21-30" morph="none" pos="word" start_char="5215">medicamentos</TOKEN>
<TOKEN end_char="5232" id="token-21-31" morph="none" pos="word" start_char="5228">tanto</TOKEN>
<TOKEN end_char="5245" id="token-21-32" morph="none" pos="word" start_char="5234">veterinarios</TOKEN>
<TOKEN end_char="5250" id="token-21-33" morph="none" pos="word" start_char="5247">como</TOKEN>
<TOKEN end_char="5255" id="token-21-34" morph="none" pos="word" start_char="5252">para</TOKEN>
<TOKEN end_char="5259" id="token-21-35" morph="none" pos="word" start_char="5257">los</TOKEN>
<TOKEN end_char="5265" id="token-21-36" morph="none" pos="word" start_char="5261">seres</TOKEN>
<TOKEN end_char="5273" id="token-21-37" morph="none" pos="word" start_char="5267">humanos</TOKEN>
<TOKEN end_char="5274" id="token-21-38" morph="none" pos="punct" start_char="5274">,</TOKEN>
<TOKEN end_char="5278" id="token-21-39" morph="none" pos="word" start_char="5276">las</TOKEN>
<TOKEN end_char="5286" id="token-21-40" morph="none" pos="word" start_char="5280">vacunas</TOKEN>
<TOKEN end_char="5288" id="token-21-41" morph="none" pos="word" start_char="5288">y</TOKEN>
<TOKEN end_char="5294" id="token-21-42" morph="none" pos="word" start_char="5290">otros</TOKEN>
<TOKEN end_char="5304" id="token-21-43" morph="none" pos="word" start_char="5296">productos</TOKEN>
<TOKEN end_char="5315" id="token-21-44" morph="none" pos="word" start_char="5306">biológicos</TOKEN>
<TOKEN end_char="5326" id="token-21-45" morph="none" pos="word" start_char="5317">destinados</TOKEN>
<TOKEN end_char="5329" id="token-21-46" morph="none" pos="word" start_char="5328">al</TOKEN>
<TOKEN end_char="5333" id="token-21-47" morph="none" pos="word" start_char="5331">uso</TOKEN>
<TOKEN end_char="5336" id="token-21-48" morph="none" pos="word" start_char="5335">en</TOKEN>
<TOKEN end_char="5342" id="token-21-49" morph="none" pos="word" start_char="5338">seres</TOKEN>
<TOKEN end_char="5350" id="token-21-50" morph="none" pos="word" start_char="5344">humanos</TOKEN>
<TOKEN end_char="5351" id="token-21-51" morph="none" pos="punct" start_char="5351">,</TOKEN>
<TOKEN end_char="5355" id="token-21-52" morph="none" pos="word" start_char="5353">así</TOKEN>
<TOKEN end_char="5360" id="token-21-53" morph="none" pos="word" start_char="5357">como</TOKEN>
<TOKEN end_char="5363" id="token-21-54" morph="none" pos="word" start_char="5362">de</TOKEN>
<TOKEN end_char="5367" id="token-21-55" morph="none" pos="word" start_char="5365">los</TOKEN>
<TOKEN end_char="5380" id="token-21-56" morph="none" pos="word" start_char="5369">dispositivos</TOKEN>
<TOKEN end_char="5388" id="token-21-57" morph="none" pos="word" start_char="5382">médicos</TOKEN>
<TOKEN end_char="5389" id="token-21-58" morph="none" pos="punct" start_char="5389">.</TOKEN>
<TRANSLATED_TEXT>The FDA, a subsidiary of the United States Department of Health and Social Services, protects public health by ensuring the protection, efficacy, and safety of both veterinary and human medicines, vaccines and other biological products intended for human use, as well as medical devices.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="5647" id="segment-22" start_char="5391">
<ORIGINAL_TEXT>La dependencia también es responsable de la protección y seguridad de nuestro suministro nacional de alimentos, los cosméticos, los suplementos dietéticos, los productos que emiten radiación electrónica, así como de la regulación de los productos de tabaco.</ORIGINAL_TEXT>
<TOKEN end_char="5392" id="token-22-0" morph="none" pos="word" start_char="5391">La</TOKEN>
<TOKEN end_char="5404" id="token-22-1" morph="none" pos="word" start_char="5394">dependencia</TOKEN>
<TOKEN end_char="5412" id="token-22-2" morph="none" pos="word" start_char="5406">también</TOKEN>
<TOKEN end_char="5415" id="token-22-3" morph="none" pos="word" start_char="5414">es</TOKEN>
<TOKEN end_char="5427" id="token-22-4" morph="none" pos="word" start_char="5417">responsable</TOKEN>
<TOKEN end_char="5430" id="token-22-5" morph="none" pos="word" start_char="5429">de</TOKEN>
<TOKEN end_char="5433" id="token-22-6" morph="none" pos="word" start_char="5432">la</TOKEN>
<TOKEN end_char="5444" id="token-22-7" morph="none" pos="word" start_char="5435">protección</TOKEN>
<TOKEN end_char="5446" id="token-22-8" morph="none" pos="word" start_char="5446">y</TOKEN>
<TOKEN end_char="5456" id="token-22-9" morph="none" pos="word" start_char="5448">seguridad</TOKEN>
<TOKEN end_char="5459" id="token-22-10" morph="none" pos="word" start_char="5458">de</TOKEN>
<TOKEN end_char="5467" id="token-22-11" morph="none" pos="word" start_char="5461">nuestro</TOKEN>
<TOKEN end_char="5478" id="token-22-12" morph="none" pos="word" start_char="5469">suministro</TOKEN>
<TOKEN end_char="5487" id="token-22-13" morph="none" pos="word" start_char="5480">nacional</TOKEN>
<TOKEN end_char="5490" id="token-22-14" morph="none" pos="word" start_char="5489">de</TOKEN>
<TOKEN end_char="5500" id="token-22-15" morph="none" pos="word" start_char="5492">alimentos</TOKEN>
<TOKEN end_char="5501" id="token-22-16" morph="none" pos="punct" start_char="5501">,</TOKEN>
<TOKEN end_char="5505" id="token-22-17" morph="none" pos="word" start_char="5503">los</TOKEN>
<TOKEN end_char="5516" id="token-22-18" morph="none" pos="word" start_char="5507">cosméticos</TOKEN>
<TOKEN end_char="5517" id="token-22-19" morph="none" pos="punct" start_char="5517">,</TOKEN>
<TOKEN end_char="5521" id="token-22-20" morph="none" pos="word" start_char="5519">los</TOKEN>
<TOKEN end_char="5533" id="token-22-21" morph="none" pos="word" start_char="5523">suplementos</TOKEN>
<TOKEN end_char="5544" id="token-22-22" morph="none" pos="word" start_char="5535">dietéticos</TOKEN>
<TOKEN end_char="5545" id="token-22-23" morph="none" pos="punct" start_char="5545">,</TOKEN>
<TOKEN end_char="5549" id="token-22-24" morph="none" pos="word" start_char="5547">los</TOKEN>
<TOKEN end_char="5559" id="token-22-25" morph="none" pos="word" start_char="5551">productos</TOKEN>
<TOKEN end_char="5563" id="token-22-26" morph="none" pos="word" start_char="5561">que</TOKEN>
<TOKEN end_char="5570" id="token-22-27" morph="none" pos="word" start_char="5565">emiten</TOKEN>
<TOKEN end_char="5580" id="token-22-28" morph="none" pos="word" start_char="5572">radiación</TOKEN>
<TOKEN end_char="5592" id="token-22-29" morph="none" pos="word" start_char="5582">electrónica</TOKEN>
<TOKEN end_char="5593" id="token-22-30" morph="none" pos="punct" start_char="5593">,</TOKEN>
<TOKEN end_char="5597" id="token-22-31" morph="none" pos="word" start_char="5595">así</TOKEN>
<TOKEN end_char="5602" id="token-22-32" morph="none" pos="word" start_char="5599">como</TOKEN>
<TOKEN end_char="5605" id="token-22-33" morph="none" pos="word" start_char="5604">de</TOKEN>
<TOKEN end_char="5608" id="token-22-34" morph="none" pos="word" start_char="5607">la</TOKEN>
<TOKEN end_char="5619" id="token-22-35" morph="none" pos="word" start_char="5610">regulación</TOKEN>
<TOKEN end_char="5622" id="token-22-36" morph="none" pos="word" start_char="5621">de</TOKEN>
<TOKEN end_char="5626" id="token-22-37" morph="none" pos="word" start_char="5624">los</TOKEN>
<TOKEN end_char="5636" id="token-22-38" morph="none" pos="word" start_char="5628">productos</TOKEN>
<TOKEN end_char="5639" id="token-22-39" morph="none" pos="word" start_char="5638">de</TOKEN>
<TOKEN end_char="5646" id="token-22-40" morph="none" pos="word" start_char="5641">tabaco</TOKEN>
<TOKEN end_char="5647" id="token-22-41" morph="none" pos="punct" start_char="5647">.</TOKEN>
<TRANSLATED_TEXT>Dependence is also responsible for the protection and safety of our national food supply, cosmetics, dietary supplements, products that emit electronic radiation, as well as the regulation of tobacco products.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="5652" id="segment-23" start_char="5650">
<ORIGINAL_TEXT>###</ORIGINAL_TEXT>
<TOKEN end_char="5652" id="token-23-0" morph="none" pos="tag" start_char="5650">###</TOKEN>
<TRANSLATED_TEXT># #</TRANSLATED_TEXT><DETECTED_LANGUAGE /></SEG>
</TEXT>
</DOC>
</LCTL_TEXT>